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ABSTRACT
CONTROL OF PROTEOLYSIS DURING THE
CAULOBACTER CELL CYCLE
MAY 2016
JOANNE YEE JIN LAU,

B. ENG, NATIONAL UNIVERSITY OF SINGAPORE

PH.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Peter Chien
Intracellular protein destruction is a carefully coordinated and timed
regulatory mechanism that cells utilize to modulate growth, adaptation to
environmental cues, and survival. In Caulobacter crescentus, a bacterium known
for studies of bacterial cell division cycle, the response regulator CpdR couples
phosphorylation events with the AAA+ protease ClpXP to provide punctuated
degradation of crucial substrates involved in cell cycle regulation. CpdR functions
like an adaptor to alter substrate choice by ClpXP, however it remains unclear
how CpdR influences its multiple targets. In this thesis, we show that, unlike
canonical ClpXP adaptors, CpdR alone does not strongly bind its substrate.
Instead, CpdR binds the N-terminal domain of ClpX and prepares (primes) the
unfoldase for substrate engagement. This priming creates a recruitment interface
that docks multiple substrates and additional adaptor components. Interestingly,
adaptor-dependent priming of ClpX avoids concentration-dependent inhibition
that limits traditional, scaffolding adaptors. Control of proteolysis during the
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Caulobacter cell cycle occurs through proteins involved in a complex
phosphosignaling network. We show that this phosphosignal disrupts the
interaction between CpdR and ClpX. This regulatory mechanism is efficient
because phosphorylated CpdR that cannot bind ClpX should, theoretically, free
ClpXP

for

interaction

with

its

other

substrates

and

adaptors.

When

dephosphorylated, CpdR binds ClpX, allowing ClpXP to temporarily gain
capability to target a completely different range of proteins. Mutations in the
predicted response regulator output face of CpdR yielded CpdR variants that
impact ClpX binding to cause ranked-order change in adaptor activity and
biological function. Through a suppressor mutant screen of a CpdR variant that is
hugely defective in binding ClpX, we discover a non-phosphorylatable activated
variant of CpdR. Our data suggest that this CpdR variant may have adopted a
Mg2+-free conformation, giving us insight to the dynamic states that CpdR can
adopt during its regulatory function. Together, these results reveal how a single
adaptor can command global changes in proteome composition through priming
of a protease.
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CHAPTER 1
INTRODUCTION TO ENERGY-DEPENDENT PROTEOLYSIS, ADAPTOR
MECHANISMS, AND CELL-CYCLE DEPENDENT DEGRADATION IN
CAULOBACTER CRESCENTUS

1.1 Regulation of cell function through AAA+ protease
Protein degradation is a necessary continuum of the central dogma of biology.
Intracellular proteins produced from transcription and translation processes
accumulate, at times are no longer needed, or decline into disorder – hence their
necessary removal by AAA+ (ATPases associated with diverse cellular activities)
proteases. Interestingly, there are few types of AAA+ proteases – the
proteasome in eukaryotes, and generally fewer than 10 different AAA+ proteases
in prokaryotes – yet these enzyme machineries are able to remodel the proteome
landscape, targeting a wide range of substrates specifically from the intracellular
pool of proteins at the right time and place. How is this done?

Structurally, AAA+ proteases are composed of an# unfoldase# and# a# peptidase
(Figure 1-1).# The# unfoldase# is# responsible# for# recognition# of# substrate# through#
binding#of#specific#degradation#motifs#in#the#substrate#(also#known#as#degrons),#
thus# positioning# the# substrate# in# proximity# to# the# unfoldase# pore# to# initiate# the#
unfolding# process.# The# unfoldase# then# unfolds# structured# folds# of# substrates#
using#energy#gained#from#ATP#hydrolysis,#feeding#the#substrate#into#the#narrow#
pore#of#the#peptidase#chamber#where#concealed#catalytic#sites#break#the#peptide#
bonds#of#the#polypeptide.##
1

Figure 1-1 How energy-dependent proteases are designed to modulate the
proteome
AAA+# proteases# are# generally# composed# of# an# unfoldase# and# a# peptidase# component.#
The# unfoldase,# on# its# own,# or# in# partnership# with# either# E3# ligases# in# eukaryotes# or#
adaptors# in# prokaryotes,# recognizes# substrates# that# are# folded# or# misfolded.# The#
unfoldase#harnesses#energy#from#ATP#hydrolysis#to#unfold#substrates,#and#translocates#
the#linearized#polypeptides#into#the#peptidase#pore#where#the#peptide#bonds#are#cleaved,#
thus#resulting#in#a#degradation#event.##

The# unfoldase# can# furthermore# expand# its# substrate# range# using# intricate#
mechanisms# to# recognize# substrates.# In# eukaryote,# the# proteasome# employs# a#
network# of# E1,# E2# and# E3# ligases,# where# E3# ligases# selectively# mark# proteins#
using# ubiquitin# motifs# to# target# them# for# degradation# by# the# proteasome.# In#
higherHorder# eukaryotes,# misregulation# of# E3# ligases# has# been# associated# with#
diseases# such# as# cancer# and# neurological# disorders# (Ardley# and# Robinson,#
2005).# In# prokaryotes,# AAA+# proteases# expand# their# substrate# repertoire# by#
pairing# with# adaptor# proteins.# AdaptorHsubstrate# pairings# in# prokaryotes# confer#
advantages# to# the# cell,# for# instance,# by# regulating# substrates# involved# in# key#
cellular# functions# including# competence# for# DNA# uptake# and# adaptability# in#
different#environments.#The#focus#of#this#thesis#is#to#understand#the#mechanism#
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of#a#key#adaptor#that#regulates#degradation#of#cell#cycleHdependent#substrates#in#
Caulobacter1crescentus.##

1.2 Adaptor mechanisms that modulate proteolysis
By definition, adaptors bring substrates to close proximity of its partner enzyme
to allow the enzyme to act upon the substrate. Proteolytic adaptors permit
substrate degradation by their cognate AAA+ protease in a similar way, however,
the mechanisms by which this process occurs in nature is complex and highly
variable. Principles that can be drawn from mechanistic studies of known
proteolytic adaptors are illustrated in the following sections. These sections will
hopefully help readers of this thesis better understand the context of our
mechanistic findings.

1.2.1 Adaptor modules based on their mode of action
Adaptors are modular (i.e. created separate from their cognate protease) and
can be typecast based on their mode of action. Adaptors can function by
interacting with both substrate and protease, or just the substrate or the protease
to initiate degradation. A scaffolding adaptor has separate binding points to its
substrate and unfoldase (Table 1A). Such attributes effectively tether the
substrate to the protease to enhance degradation, as in the case of the adaptor
SspB where its structural domains (substrate-binding domain and proteasebinding domain) have been clearly demarcated and structurally characterized
(Wah et al., 2003; Bolon et al., 2004a; Chien et al., 2007a; Park et al., 2007;
3

Chowdhury et al., 2010). Substrate-priming adaptors typically interact with their
cargo substrates, and prepare substrate for recognition by the unfoldase (Table
1B). In contrast with scaffolding adaptors, substrate-priming adaptors do not
show detectable interactions with their protease. For example, the RssB adaptor
induces degradation of the RpoS stationary sigma factor by binding RpoS and
promoting ClpX recognition, but RssB alone appears to bind poorly to ClpX
(Zhou et al., 2001a; Stüdemann et al., 2003; Hengge, 2009). Protease-priming
adaptors, populated only by the adaptor CpdR to date, based on studies in this
thesis (Lau et al., 2015), primarily interacts with its cognate protease, but not its
substrate, so as to prepare the protease to recognize the substrate (Table 1C).

Categorizing adaptors based on whether they act on substrate, protease, or both,
is a broad stroke on the molecular mechanism of how adaptors actually act on
their partner(s). Studies have shown that adaptors may not only provide binding
contacts that are necessary to bring about substrate delivery to the protease, but
also can act on its partner(s) in a complex manner at the molecular level. The
scaffolding adaptor, MecA, for instance, not only binds both its protease and
substrate partners, but is essential for formation of the oligomeric structure of its
cognate AAA+ unfoldase ClpC, thus regulating the basic function of the protease

4

Table 1-1 Types of adaptor modules categorized based on the content and function of their structural domains
Known adaptors are categorized as scaffolding adaptors, substrate-priming adaptors, or protease-priming adaptors based on mechanistic studies
that were performed to determine whether the adaptor modulates its substrate and/or protease.
Types of adaptor modules
(A) Scaffolding adaptors
Has substrate-binding, and
protease-binding domains
that together bring the substrate to
close proximity of the protease.
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(B) Substrate-priming adaptors
Has substrate-binding domain,
prepares substrate for recognition
by protease.

(C) Protease-priming adaptors
Has protease-binding domain,
prepares protease to recognize
substrate.

Adaptors
SspB

Protease
ClpXP

Substrate
ssrA-tagged proteins
RseA

Pathways influenced
Translational stalling
Extracytoplasmic stress
response

ClpS

ClpAP

N-end rule substrate

Protein half-life

MecA

ClpCP

ComK, ComS
Misfolded, aggregated
proteins

DNA uptake, recombination
Quality control

ComS anti-adaptor

PopA

ClpXP

CtrA

Cell cycle, differentiation

Cyclic-di-GMP

RcdA

ClpXP

Cell cycle, differentiation

RssB

ClpXP

TacA, CC3144,
CC2323
RpoS

CpdR phosphorylation, other
substrates as anti-adaptor
Phosphorylation, anti-adaptors
IraD/L/M/P

YjbH

ClpXP

Spx

Disulfide stress

Not known

FliT

ClpXP

FlhC

Flagellar biogenesis

Not known

YdiV

ClpXP

FlhDC

Flagellar biogenesis

Not known

CpdR

ClpXP

PdeA, McpA

Cell cycle, differentiation

CpdR phosphorylation

Stress response

Adaptor regulation
None known
None known

Legend for the cartoons: Blue=Adaptor, White=Substrate, Grey=Protease, S=Substrate-binding, P=Protease-binding, dotted line indicate priming mechanism

(Kirstein et al., 2006). In kind, the substrate-priming adaptor RssB acts by
modulating changes in the conformation of its substrate, RpoS, thus revealing
the substrate degron that can be recognized by the AAA+ protease ClpXP
(Stüdemann et al., 2003). Interestingly, in turn, AAA+ proteases can act on their
adaptors to facilitate the delivery process. The scaffolding adaptor ClpS, for
instance, is responsible to deliver N-end rule substrates to the AAA+ protease
ClpAP. Upon formation of the substrate-adaptor-protease ternary complex, the
AAA+ protease ClpAP engages the N-terminal extension of ClpS in order to
promote substrate transfer into the unfoldase pore (Rivera-Rivera et al., 2014).

1.2.2 Building blocks engineered to modulate the proteome
How do adaptors expand the substrate repertoire of their cognate AAA+
protease? Some adaptor proteins are dedicated to only one protein substrate per
adaptor (Figure 1-2A). For instance, the RssB adaptor is known to date to deliver
only RpoS. Other adaptors can deliver multiple substrates with diverse degron
sequence (Figure 1-2B). SspB, for instance, can not only deliver substrates that
contain ssrA degron, but also a transmembrane protein RseA that contains a
degron sequence appearing to be different from ssrA-tagged substrates (Flynn et
al., 2004). Multiple adaptors can even function in tandem (Figure 1-2C), as found
recently for CpdR, RcdA and PopA adaptors that function together to recruit
many more substrates simultaneously in a manner that may not be sufficiently

6

Figure 1-2 Adaptor building blocks designed to deliver their cargo
substrate to AAA+ proteases
Principles drawn from known examples in nature: (A) Some adaptors have a one-on-one
relationship with their substrates, but others (B) expand their substrate repertoire
through their ability to recognize more than one degron, thus delivering a diverse range
of substrates. (C) Adaptors can arrange in tandem, interacting in tiers to provide multiple
platforms for substrate recruitment. Alternatively, (D) multiple adaptors can be assigned
to a specific substrate.

achieved by one adaptor alone (Smith et al., 2014; Joshi et al., 2015; Lau et al.,
2015).

Yet, counterintuitive to the idea of expanding the substrate repertoire through
adaptors, it has been reported that multiple adaptors can be designated to target
a singular functional pathway (Figure 1-2D). In the case of FlhDC substrate
complex in Salmonella typhimurium, the adaptor YdiV binds to FlhD, while the
adaptor FliT binds to FlhC to enable delivery of the complex to ClpXP (Takaya et
al., 2012; Sato et al., 2014). In vitro studies show that each adaptor on its own is

7

sufficient to disrupt the FlhDC complex activity in flagellar formation. It is
uncertain why multiple adaptors are designated towards the degradation of the
FlhDC complex. Perhaps multiple adaptors work cooperatively to ensure speedy
delivery. Redundancy in the adaptor network could also be a means to guarantee
regulation of an important cell function. In this case, the substrate FlhDC is key
for flagellar biogenesis, which is important for regulation of bacterial locomotion
and sensing of external chemicals and temperature. Having multiple adaptors for
a particular pathway could also allow incorporation of different cues to execute
the final outcome of disrupting flagellar biogenesis as necessary.

Perhaps a most obvious and targeted strategy to modulate protein composition is
by honing in on substrates whose function influences large transcriptional
networks. For instance, the adaptor RssB targets RpoS which regulates a large
number of processes due to ability to modulate approximately 400-500 genes
(Landini et al., 2014; Schellhorn, 2014). The YdiV and FliT adaptors which
targets the FlhDC complex, disrupt the earliest stage of the multi-tiered
transcriptional flagella regulon (Takaya et al., 2012; Sato et al., 2014). In the
case of the tandem adaptors CpdR-RcdA-PopA, large transcriptional networks
are modulated by targeting key transcriptional regulators such as CtrA and TacA
as degradation substrates (Laub et al., 2002; Biondi et al., 2006a). The use of
adaptors to target key transcriptional pathways reveals patterns of sophistication
in regulated proteolysis. Crudely put, targeting substrates that are at the heart of
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main processes can be a highly efficient strategy, providing the "biggest bang for
the buck" to modify the proteome landscape.

1.2.3 The substrate dictates the need for a constitutive or regulatable
adaptor
Adaptors allow for or enhance substrate degradation by their cognate AAA+
protease, however, when this process is regulated depends on the nature of the
substrate. Borrowing the language used to describe genetic promoters
(‘constitutive promoters’ versus ‘inducible promoters’), adaptors SspB and ClpS
can be classified as constitutive (always functioning) adaptors. SspB targets
translationally-stalled ssrA-tagged polypeptides for degradation by ClpXP. The
ssrA tag itself is a degron, so degradation occurs even without SspB but is
enhanced due to SspB. Constitutive and immediate delivery of ssrA-tagged
substrates makes sense due to the potentially damaging effects of partially
expressed proteins. The adaptor ClpS targets N-end rule substrates to ClpAP.
The destabilizing residues at the N-terminus of the substrate dictates the rates of
degradation, hence determining its protein half-life (Erbse et al., 2006; Wang et
al., 2007). Like in the case of ssrA-tagged substrates, N-end rule substrates can
be slowly degraded in the absence of ClpS but occurs much more efficiently in
the presence of ClpS (Wang et al., 2007). Notably, both adaptors SspB and ClpS
are present in constant amounts throughout bacterial growth cycle (Farrell et al.,
2005; Lessner et al., 2006). The constitutive presence of these adaptors, i.e. in a
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manner impervious to environmental conditions, makes sense given the nature of
their target substrates.

Regulatable adaptors can be classified as adaptors that deliver their substrate(s)
on cue. Complex regulatory pathways typically converge through the adaptor to
regulate the function of the substrate. For instance, the adaptor RssB degrades
the stationary stress response sigma factor RpoS during exponential phase, and
cease adaptor activity under stressful situations (Hengge, 2009). Different
stressors induce different anti-adaptors to inhibit RssB from delivering RpoS to
ClpXP (Battesti et al., 2013). Furthermore, the phosphorylation state of RssB
regulates its ability to bind its substrate (Klauck et al., 2001; Zhou et al., 2001b).
The adaptor CpdR, which is the focus of this thesis study, acts specifically at the
G1-S transition of the cell cycle, removing proteins that function during G1 phase
(Iniesta et al., 2006; Kobayashi et al., 2009). CpdR is regulated through a
complex cascade of phosphosignaling proteins and cyclic-di-GMP modulators
(Figure 1-4) (Biondi et al., 2006b; Iniesta et al., 2006; Iniesta and Shapiro, 2008;
Lori et al., 2015). Complex means of adaptor regulation provides the opportunity
to vary adaptor activity according to different environmental stimuli, similar to
multiple inputs feeding to a decision point. This fine modulation of the proteome
can confer advantage to bacteria cells as the microbes explore or encounter
varying environmental conditions.
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1.3 Proteolysis during Caulobacter crescentus cell cycle and cell
differentiation
1.3.1 C. crescentus as a model organism for proteolytic studies
C. crescentus is a gram-negative, oligotrophic alpha-proteobacteria that has
emerged as an important model organism for studying the bacterial cell cycle and
cell differentiation (Figure 1-3). Unlike Escherichia coli that begins a new round of
replication before the previous has terminated, C. crescentus initiate DNA
replication once only per cell cycle. C. crescentus cells are easily synchronized,
allowing isolation of cells from the beginning of cell cycle. This synchronization
technique has been fundamental in illustrating the importance of proteolysis in
governing bacterial cell cycle (Jenal, 2009).

1.3.2 Regulation of ClpXP activity during the Caulobacter cell cycle
The highly conserved protease ClpXP is a key AAA+ protease that regulates cell
cycle-dependent proteolysis in Caulobacter crescentus (Jenal, 2009). During the
cell cycle, a non-replicative, motile swarmer cell differentiates into a replicationcompetent, stalked cell producing G1 and S stages analogous to the eukaryotic
cell cycle stages (Degnen and Newton, 1972) (Figure 1-3). The stalked cell then
divides asymmetrically into swarmer and stalked cells that execute specific
molecular programs for motility and replication respectively. Levels of many
biomolecules such as mRNAs, proteins, and second messengers (e.g. cyclic di-
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GMP) are cell-cycle regulated (Kirkpatrick and Viollier, 2012). Interestingly,
neither ClpX (the unfoldase component) nor ClpP (the peptidase component)
levels change during cell cycle (Jenal and Fuchs, 1998), but numerous proteins
are degraded by ClpXP in a cyclic manner dependent on the response regulator
protein, CpdR (Figure 1-3) (Biondi et al., 2006b; Iniesta et al., 2006;
Radhakrishnan et al., 2010; Abel et al., 2011; Bhat et al., 2013).

CpdR activity is restrained through an intricate phosphorylation network during
the swarmer cell stage (Figure 1-4) (Biondi et al., 2006b; Iniesta et al., 2006; Lori
et al., 2015). This phosphorylation network consists of two sets of
phosphosignaling pathways that are disconnected during the swarmer cell stage,
allowing for phosphorylation of CpdR (Figure 1-4, left). During the swarmer to
stalk transition, these phosphosignaling pathways converge to activate
dephosphorylation of CpdR (Figure 1-4, right) thus activating ClpXP protease
activity (Iniesta et al., 2006; Chen et al., 2009; Lori et al., 2015).
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Figure 1-3 Cell cycle-dependent oscillations

C. crescentus undergoes an asymmetric cell cycle, where DNA replicates only once
during each cell cycle. Motile swarmer cells are in the non-dividing G1 phase of the cell
cycle. When they discover sufficient nutrient, these cells transition into the S phase by
forming stalks in place of flagella and pili so that they adhere to the location with high
nutrient density. DNA synthesis then occurs to support the G2/M cell divisional phase.
Daughter cells are asymmetric from mother cells as seen from their respective swarmer
and stalked phenotypes. Daughter cells search for new nutrient-rich environments so
that the cell cycle repeats.
The protein CpdR changes phosphorylation state during the cell cycle. The
phosphorylated form of CpdR is inactive, while the unphosphorylated form of CpdR
activates ClpXP-dependent delivery of substrates such as CtrA (CtrA levels shown in
Western blot, with ClpP levels shown as loading control). Without CpdR, levels
of substrates such as CtrA cease to oscillate during the cell cycle. Western blot
results reproduced in lab based on Iniesta et al., 2006.
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Figure 1-4 Bipartite phosphosignaling networks control ClpXP-dependent
proteolysis during the Caulobacter cell cycle
Swarmer cells modulate CpdR phosphorylation through the kinase activity of a
phosphorylation cascade consisting of the phosphotransferase ChpT, a histidine kinase
CckA, and DivL which maintains CckA autophosphorylation state. Separately, a
phosphatase PleC (yellowed) keeps a response regulator DivK and diguanylate cyclase
PleD (which catalyzes cdG production) in an inactive state in swarmer cells. ClpXP is
active in its ability to degrade protein substrates other than cell cycle factors.
Upon transition into the stalked cell state, a histidine kinase DivJ (yellowed)
phosphorylates DivK and PleD. Phosphorylated DivK binds to DivL so that CckA reverse
into phosphatase mode, and phosphorylated PleD produce the small molecule cyclic-diGMP (cdG) which binds CckA to stimulate its phosphatase activity. This causes ChpT
transfers phosphate from CpdR to CckA. As a result, the CckA-ChpT phosphorylation
cascade functions in reverse to dephosphorylate CpdR, and cause CpdR to activate
degradation of cell cycle factors by ClpXP.
Note: CtrA is not drawn as the other terminal receiver of phosphate besides CpdR to
simplify the diagram.
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1.3.3 Localization mechanism driving ClpXP-dependent degradation led to
discovery of adaptor mechanism
CpdR is needed for the subcellular localization of ClpXP and this function was
thought to promote degradation of similarly localized substrates such as the
essential replication regulator CtrA (Figure 1-5) (Iniesta et al., 2006; McGrath et
al., 2006). In support of this regulatory mechanism, components needed for CtrA
localization are also important for its degradation in vivo (Figure 1-5) (McGrath et
al., 2006; Duerig et al., 2009). However, subsequent biochemical work suggested
that CpdR could also work as an adaptor outside the internal organization of the
bacterium to drive substrate degradation by ClpXP.

In vitro reconstitution experiments with highly purified proteins showed that CpdR
is necessary and sufficient to stimulate degradation of a cyclic-di-GMP
phosphodiesterase PdeA by ClpXP (Abel et al., 2011). The cellular components
needed for substrate localization can assemble as a multi-protein adaptor
complex that enhances degradation of CtrA and other substrates in a CpdRdependent manner in vitro (Smith et al., 2014; Joshi et al., 2015; Lau et al.,
2015). In these studies, it was shown that phosphorylation of CpdR inactivated
delivery to ClpXP, mirroring what was observed in vivo. Taken together, these
reconstituted systems clearly indicate that a localization mechanism alone does
not drive cell cycle-dependent activity of ClpXP.
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Figure 1-5 Localization mechanism driving ClpXP-dependent degradation
in Caulobacter
Multiple proteins, when examined by fluorescent protein tagging, localize to the stalked
cell pole when C. crescentus transitions from swarmer to stalked cell phenotype during
the G1-S phase of the cell cycle (Iniesta et al., 2006; McGrath et al., 2006; Duerig et al.,
2009; Abel et al., 2011).
This phenomenon is illustrated in this cartoon, where the protein that modulates
ClpX localization; CpdR (solid green circle), protein factors that modulate substrate
localization; RcdA and PopA (open green circle), ClpXP (solid black circle) and cellcycle-dependent protein substrates; CtrA, PdeA, and McpA (solid white circle), are
shown to disperse in swarmer cells.
These proteins relocate to the stalked pole during the swarmer to stalked cell
transition (G1-S), thus forming a fluorescence foci due to the fluorescent protein tagging.
Substrates (solid white circle) are degraded upon transition into stalked cell phase, and
the other components appear to disperse again.
It is known that deleting CpdR abolishes ClpX stalked pole foci formation during
G1-S, and this indicates that CpdR is important for ClpX localization to the stalked pole.
RcdA and PopA deletion impacts the emergence of foci for CtrA substrate, but not the
substrates PdeA and McpA.
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Figure 1-6 A combinatorial adaptor mechanism drives delivery of multiple
substrates to ClpXP during the Caulobacter cell cycle
Three adaptors (CpdR in green, RcdA in red, and PopA in yellow) function in tandem to
drive the delivery process for multiple substrates during the G1-S Caulobacter cell cycle
transition.
CpdR is critical for priming the protease in order to deliver substrates. The
adaptor RcdA has scaffolding attributes that allows it to bind to CpdR and deliver
substrates. The adaptor PopA also has scaffolding attributes that allow it to bind to RcdA
and deliver a substrate.
Given that the adaptors bind to one another in tandem, CpdR is important to
control whether the other adaptors, RcdA and PopA, can bind to ClpX. CpdR is
regulated by its phosphorylation status and its ability to be degraded by ClpXP. RcdA is
regulated by degradation. PopA binding to its substrate is regulated by the small
molecule cyclic-di-GMP.

The mechanism by which the adaptors CpdR, RcdA and PopA function have
become the subject of intense study in the last several years, culminating in an
intricate model that illustrates how adaptor modules can combine to deliver
multiple cell cycle substrates (Figure 1-6) (Smith et al., 2014; Joshi et al., 2015;
Lau et al., 2015). CpdR, RcdA, and PopA adaptors function in tandem to drive
this delivery process (Figure 1-6). CpdR provides a regulatory layer through its
protease-priming mechanism so that the scaffolding adaptors RcdA and PopA
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can bind in tandem (Figure 1-6). Each of these adaptors contributes to the
delivery of multiple diverse cell cycle factors. These adaptors are furthermore
highly regulated. CpdR is regulated by its phosphorylation status and its own
ability to be degraded by ClpXP (Abel et al., 2011; Smith et al., 2014; Lau et al.,
2015). RcdA is regulated by expression and degradation (a more current work
done by Kamal Joshi in Chien Lab). The ability of PopA to bind its substrate is
regulated through the differential concentrations of the small molecule cyclic-diGMP in swarmer versus stalked cells (Smith et al., 2014).

1.3.4 Relevance of the adaptor mechanistic studies due to co-conservation
in a number of alpha-proteobacteria
The focus of this thesis is to understand the mechanism of CpdR as an adaptor,
determine how phosphorylation modulates its adaptor mechanism, and
understand whether both adaptor and localization mechanism co-exist in nature.

Comprehending the adaptor mechanism of CpdR in C. crescentus will potentially
be relevant to understand cell cycle regulation in medically and agriculturally
important alpha-proteobacteria where the CpdR gene is conserved. CpdR is
important for pathogenesis in the Brucella abortus, where constitutive activity of
CpdR disrupts infection of human phagocytic cells (Willett et al., 2015). In
rhizobium Sinorhizobium meliloti, removal of CpdR gene abolishes the ability to
fix nitrogen during symbiosis with legumes, however the mechanism of action is
still not understood (Kobayashi et al., 2009). CpdR from C. crescentus can
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furthermore functionally complement the ortholog in S. meliloti (Kobayashi et al.,
2009). The genetic and biochemical tools for studying the C. crescentus ortholog
of CpdR are more developed at this point in time. Mechanistic studies based on
the CpdR ortholog in C. crescentus will likely be applicable to CpdR orthologs in
related bacteria in the future.

1.4 Thesis structure
This thesis describes efforts to elucidate the mechanism by which CpdR
functions as an adaptor in C. cresentus. The current chapter, Chapter 1,
introduces proteolytic adaptors and highlight research findings that help readers
appreciate the bigger picture surrounding the work described in this thesis.

Chapter 2 of this thesis describes efforts to pinpoint the adaptor mechanism for
CpdR. Chapter 3 describes the discovery of a protease-priming mechanism,
though still not fully explicable at this point, implies that a more intimate
relationship between CpdR and the N-terminal domain of ClpX exists. Chapter 4
describes efforts to understand how phosphorylation impacts the adaptor
mechanism of CpdR. Mutations in the predicted response regulator output face
of CpdR yielded variants that were less able to interact with ClpX. A follow-up
suppressor mutant study, through work in collaboration with Ying Qi Zhang (an
undergraduate student in the Chien Lab), is also presented to show an activated
variant of CpdR that cannot be phosphorylated. Chapter 5 describes how the
CpdR adaptor mechanism extends to other cell cycle-regulated substrates.
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Substrate and adaptor mechanism from the work of Kamal Joshi (PhD student in
Chien Lab) and Lisa Hernandez-Alicea (Masters student in Chien Lab) are
discussed. The localization mechanism is also discussed in light of the
discovered adaptor mechanisms. The concluding chapter, Chapter 6, contains
the model for CpdR adaptor mechanism. Chapter 7 describes proposed future
directions related to this body of work. All materials and methods used in this
study are described in Appendix 1.

1.5 CpdR protein sequence and known mutants
This is a short description about CpdR for reference. CpdR is a small 118 amino
acid protein (Figure 1-7). Phosphorylation modulates CpdR function in mediating
activity of the AAA+ protease ClpXP, and previous studies using a CpdR D51A
variant indicate that D51 is the site for phosphorylation of CpdR (Iniesta et al.,
2006) (Figure 1-7). CpdR is known to be degraded in a phosphorylationdependent manner (Iniesta and Shapiro, 2008). The degradation tag (or degron)
that is recognized by ClpXP consists of di-alanine residues located at CpdR Cterminus (Figure 1-7). Currently, there is no protein structural information for
CpdR.
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Figure 1-7 Location of phosphorylation site and ClpX degron in CpdR

The amino acid Asp51(D51) in CpdR is the site for phosphorylation, and mutation to
alanine destroys the site of phosphorylation. The C-terminal di-alanine (AA) residues
constitute a recognition site (degron) for ClpX that results in CpdR degradation by its
cognate AAA+ protease ClpXP. Mutation of the C-terminal di-alanine to di-aspartate
(DD) abolishes CpdR degradation by ClpXP.
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CHAPTER 2
THE ADAPTOR CPDR INTERACTS PRINCIPALLY WITH CLPX TO
ASSEMBLE A DELIVERY COMPLEX

2.1 Introduction – differentiating between adaptor mechanisms
This chapter describes our earliest efforts in elucidating how CpdR works
mechanistically. The discovery that PdeA can be delivered to ClpXP in a CpdRdependent manner (Figure 2-1) (Abel et al., 2011) opened up mechanistic
questions that could be asked of a simple delivery unit that consist of the
substrate PdeA, the protease ClpXP, and the adaptor CpdR. PdeA has been well
characterized (Christen et al., 2005; Rood et al., 2012), and C. crescentus ClpXP
is highly similar to the well-studied E. coli ClpXP, thus reducing the unknowns for
study of CpdR in this delivery system.

Prior to our work, it was a general consensus in the scientific field that a
fundamental aspect of proteolytic adaptors is the ability to bind to its cargo
substrates. As previously explained (Chapter 1), known adaptors can be typecast
as scaffolding adaptors that bind to both substrates and unfoldases, or substratepriming adaptors that bind substrates to prepare substrates for recognition by the
unfoldases. CpdR-ClpX, CpdR-PdeA, and ClpX-PdeA interactions had been
detected by bacterial adenylate cyclase two-hybrid (BACTH) assays (Figure
2-1B) (Abel et al., 2011). The BACTH ClpX-PdeA interactions could be explained
since the C-terminus of PdeA contain a weak degron that is recognized directly
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Figure 2-1 Degradation of PdeA by ClpXP when mediated by CpdR
(A)! The protease ClpXP degrades PdeA in a CpdR-dependent manner. In vitro
degradation reaction shows PdeA degradation over the time period of an hour. An
ATP regeneration system and 1mM GTP (which enhances PdeA degradation) is
present in the degradation reaction. The presence of CpdR determines whether
PdeA is degraded by ClpXP.
(B)! Interactions between CpdR, ClpX and PdeA detected by bacterial adenylate cyclase
two-hybrid (BACTH) studies. This interaction study suggests that CpdR contains
protease-binding (P) and substrate-binding (S) domains like the scaffolding adaptor,
SspB. Results shown in A and B are reproduced in lab based on Abel et al., 2011.

by ClpXP (Rood et al., 2012). The BACTH CpdR-ClpX and CpdR-PdeA
interactions suggest that CpdR behaves like a scaffolding adaptor to provide an
additional link between PdeA and ClpX (Figure 2-1B). This hypothesized model
is similar to how the known AAA+ protease ClpXP adaptor SspB functions, where
the ssrA substrate itself is a strong degron that ClpX can recognize on its own,
and SspB contains a clear substrate-binding and protease-binding domain to
tether ssrA-tagged substrates to ClpX. The first research efforts described in this
chapter therefore reflected our initial assumption that CpdR is a scaffolding
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adaptor that contains both a substrate-binding domain and protease-binding
domain.

CpdR can stimulate the ATPase rates of ClpX, but not when ClpP is present
(unpublished in vitro observation by Dr Peter Chien). It was not certain whether
the effects of CpdR on ClpX ATPase activity genuinely reflects an activation
mechanism for CpdR adaptor function since the effect is abolished in the
presence of ClpP. ATPase rates measured in the presence of the peptidase
partner ClpP should better mimic conditions of a degradation reaction. To add to
the confusion in interpretation, ClpP, in general, is known to dampen ClpX
ATPase rate (Burton et al., 2003) (based on studies for E. coli orthologs of
ClpXP), so it was difficult to conclude with certainty whether CpdR truly activates
the ATPase rates of ClpXP as part of its adaptor mechanism.

Interestingly, the E. coli ortholog of the adaptor SspB is also known to stimulate
ATPase rates of ClpX, potentially altering the enzymatic properties of ClpX (Wah
et al., 2002). However, this stimulatory role is not necessary for SspB adaptor
activity since it was previously shown that it is not detrimental to the adaptor
activity if the natural contact point between SspB and ClpX is replaced (Park et
al., 2007; Davis et al., 2009). Still, it is enticing to imagine that CpdR could be
impacting the unfolding abilities of ClpXP through an activation mechanism that
aid in the unraveling of substrate structural properties. ATP hydrolysis is critical
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for the AAA+ unfoldase ClpX to drive conformational changes that allows
unfolding and translocation of substrate prior to degradation. This could be a
strategic mechanism that allows CpdR to modulate delivery of proteins that are
co-localized at the stalked pole of C. crescentus. In parallel to my time of PhD
study, Jing Liu (PhD student in Chien Lab) discovered that unfolded proteins can
stimulate the AAA+ protease Lon to degrade a folded substrate (Jonas et al.,
2013). Therefore, we followed up on whether the adaptor mechanism for CpdR
includes the modulation of ClpX ATPase rates towards substrate degradation.

It turns out that the hypotheses that CpdR is a scaffolding adaptor and activator
of ClpX ATPase rates were not supported experimentally. Fortunately, our
studies of the interactions between CpdR, ClpX, and the substrate PdeA, began
to inform us that CpdR functions by interacting directly with the protease in order
to allow for interactions with the substrate PdeA.

2.2 CpdR does not behave like a scaffolding adaptor
2.2.1 Anchoring CpdR to ClpX using the SspB ClpX-binding (XB) module
The well-characterized SspB adaptor contains a ClpX-binding module in its Cterminal 7-8 amino acid residues (Chien et al., 2007a). We hypothesized that if
CpdR is a scaffolding adaptor that contains binding sites for protease and
substrate, mutagenesis studies may uncover residues that are important for
adaptor binding with protease or substrate.
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We identified a C-terminal conserved surface residue H104 within the signaling
output face of CpdR (full length CpdR is 118 amino acid) that when mutated to
alanine disrupted delivery of PdeA (Figure 2-3B). We initially assumed and later
found evidence that support that the CpdRH104A variant is deficient in binding to
ClpX (assayed by BACTH in Figure 2-3D). CpdRH104A protein tertiary fold
appears similar to wildtype CpdR when evaluated based on its tertiary unfolding
patterns (Appendix 2A(ii)). CpdRH104A protein is also properly recognized for
phosphorylation by its upstream phosphorelay CckA/ChpT (Appendix 2B),
indicating an intact structure.

We set out to reintroduce binding to ClpX using the ClpX-binding (XB) domain
from C. crescentus SspB (Chowdhury et al., 2010), and created a genetic
construct to produce a fusion protein where the XB module is attached to the Cterminus of CpdRH104A (Figure 2-3A). We expected CpdRH104A-XB to
deliver PdeA to ClpXP if (1) CpdRH104A can now anchor to ClpXP through
the XB module, and (2) CpdRH104A still contains an intact substrate-binding
domain that is unaffected by the H104A mutation.
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Figure 2-2 Schematic of the alanine mutagenesis study performed on
CpdR based on a homology model predicted using Phyre
The CpdR H104A mutation severely disrupts binding to ClpX, causing loss in adaptor
function. CpdR R106A led to intermediate losses. The other mutants, D107A, E111A,
and K114A, did not show any impact on adaptor function.
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Figure 2-3
Tethering a ClpX-binding deficient variant of
CpdR (CpdRH104A) onto ClpX using the SspB ClpX-binding (XB) module
does not definitively recover adaptor activity
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(A)! Hypothesizing that CpdR is a scaffolding adaptor (green), it should contain a
substrate-binding (S) and protease-binding (P) domains. Substrate is shown in
white, and protease is shown in grey. Shown in the box is the mutation H104A in
CpdR that impairs its ability to bind to ClpX, so attachment of a ClpX-binding (XB)domain (domain from the SspB adaptor) should recover CpdR binding to ClpX to
enable substrate delivery.
(B)! Phyre homology model (RcsC receiver domain as template) for CpdR. Predicted α4β5-α5 signaling output face (yellow), with conserved residues amongst αproteobacteria CpdR orthologs (orange). CpdRH104A was examined for its ability to
mediate degradation of GFP-PdeA by ClpXP.
(C)! The C-terminus of CpdRH104A was genetically fused to the XB-module.
CpdRH104A-XB purified protein is examined by Coomassie SDS gel to verify its
molecular weight increase due to addition of the XB-module. CpdRH104A and CpdR
wildtype (WT) are also examined at equimolar concentrations.
(D)! BACTH assay using McConkey agar results in red colonies when interacting
proteins are fused to complementary fragments of adenylate cyclase, T18 and T25.
Representative images are shown from three sets of independent colonies. Cells
images shown are obtained from the same plate at the same time.
(E)! The adaptor function of CpdRH104A and CpdRH104A-XB was compared based on
their ability to deliver GFP-PdeA to ClpXP.
(F)! Untagged and XB-tagged counterparts were compared for CpdR wildtype and
CpdRH104A. Initial rates of degradation of GFP-PdeA as a function of adaptor
concentrations were plotted. Column graph: mean, SD, n=3.
(G)! (i) In vitro degradation of CpdR wildtype and its non-degradable variant CpdR DD
(C-terminal Ala-Ala mutated to Asp-Asp) by ClpXP). (ii) In vitro degradation of
substrate GFP-PdeA by ClpXP in the presence of increasing concentrations of
CpdR WT/DD.
(H)! In vitro degradation of substrate GFP-PdeA by ClpXP in the presence of CpdR
H104A compared to its non-degradable variant CpdRH104ADD and CpdRDD.
nb. Experiments E & F were performed years before experiments G and H were
performed, and it is noted that the actual rates of delivery is not comparable between
years because the overall rates of degradation reaction during the time when E & F were
carried out was generally lower than what we considered normal due to variability in
ClpXP or the ATP regeneration mix. However, comparison of adaptor activity within each
figure is valid. Also, the contrast in activity profiles (Kactivation measured at varying adaptor
concentrations) between CpdR wildtype and its weaker variant CpdRH104A remained
consistent through the years regardless of variability in ClpXP or ATP regeneration mix.

XB-tagging improved delivery of PdeA by CpdRH104A (Figure 2-3F). We note
that the effect seen at 8µM CpdRH104A-XB in Figure 2-3E is not as prominent
as that independently observed in Figure 2-3F at the same concentration, and
also does not recover CpdR wildtype activity (Figure 2-3F). Using BACTH
assays,

we

could

detect

small

improvements
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in

interaction

between

CpdRH104A-XB and ClpX, as compared to CpdRH104A (Figure 2-3D). The
BACTH CpdRH104A-XB interaction with ClpX indicated that the C-terminus tail
of CpdR where XB is fused is available for binding to ClpX. Oddly, addition of the
XB-module did not improve wildtype activity (Figure 2-3F), and reduced the
apparent interaction between wildtype CpdR and ClpX (Figure 2-3D). The
negative impact on CpdR interaction with ClpX could be due to XB domain
competing with normal CpdR within the same protein to bind to ClpX, thus
reducing the overall binding of CpdR-XB.

The data essentially show that XB-tagging slightly improves CpdRH104A ability
to deliver PdeA, but does not recover activity to levels similar to wildtype CpdR or
CpdR-XB (Figure 2-3E,F). Does this result support the hypothesis that CpdR
contains a substrate-binding domain?

Incomplete recovery of CpdRH104A-XB to wildtype CpdR activity could be
explained in numerous ways: (1) The H104A mutation may not only impact the
protease-binding domain, but also impact the substrate-binding domain,
therefore robust delivery cannot be recovered simply by tethering CpdRH104A to
the protease, (2) CpdRH104A binding to ClpX using the XB domain is not tight
enough, or may have mis-positioned CpdR, in turn causing the substrate PdeA to
be positioned incorrectly near the unfoldase ClpX.
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Arguably, the slight improvement in adaptor activity for CpdRH104A-XB
compared to CpdRH104A is consistent with there being a substrate-binding
domain in CpdRH104A. However, a natural artifact of the delivery system (that
was better understood later during this PhD work) may explain the improvement
in CpdRH104A when tagged with the XB-domain:

1.! Degradation of CpdR by ClpXP suppresses adaptor activity at high
concentrations of adaptor, but this effect is mitigated in a nondegradable variant of CpdR (CpdRDD) (Figure 2-3G) because CpdR is
no longer a substrate that competes for degradation by ClpXP.

2.! CpdRH104A substrate nature also suppresses its adaptor activity, and the
effect can also be mitigated in its non-degradable variant (Figure 2-3H).
Like CpdR wildtype, CpdRH104A can be degraded by ClpXP (data not
shown). Being a substrate of ClpXP hampered its full ability to behave as
an adaptor (Figure 2-3H).

3.! XB-tagging blocks the CpdRH104A C-terminus. Similar to CpdRH104ADD
variant, this probably alleviated the suppressive effect of CpdRH104A due to
itself being a substrate for ClpXP.
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This XB-fusion study alone cannot prove or disprove that CpdR contains a
substrate-binding domain because the improvement in delivery by tagging
CpdRH104A C-terminus with XB may be attributed to an artifact due to Cterminal tagging with the XB-domain, similar to the activating effects of the Cterminus DD in CpdRH104A (Figure 2-3H). Later in the course of our studies, the
idea that CpdR, on its own, cannot bind substrate, gained foothold due to
evidence gathered through other experimental approaches described in this
thesis. It is important, however, to document this XB-fusion study (which hinted
that CpdR may contain a substrate-binding domain) to give an unbiased
representation of our data.

2.2.2 Fusing CpdR to ΔN-ClpX as a single polypeptide

Direct fusion of the adaptor SspB to the unfoldase ClpX (E. coli orthologs) is
known to enhance delivery of the model substrate GFP-ssrA, when compared to
ClpX sans adaptor (Park et al., 2007). We tried a similar fusion approach to see
whether CpdR can deliver substrates when fused to ClpX that lacked its Nterminal domain (Figure 2-4A). If PdeA can be delivered using this chimeric
adaptor-protease protein, this indicates that CpdR, on its own, contains a
substrate-binding domain.

His-thrombin-tagged CpdR-ΔN-ClpX fusion was genetically constructed for
affinity purification. During the protein purification steps, the activity of CpdR-ΔN-
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ClpX was verified using GFP-ssrA since the ssrA degron is recognized by the
central pore loop of the ATPase domain (Martin et al., 2008). CpdR-ΔN-ClpX
appears to be unstable because the first batch of purification eventually lost its
enzymatic activity towards GFP-ssrA. Possibly due to the instability of the variant
protein, activity towards GFP-ssrA did not always match up to CpdR-ΔN-ClpX
concentrations, unlike ClpX and ΔN-ClpX (data not shown). Therefore, GFP-ssrA
activity was used as a normalizing factor when comparing enzyme activity in
degradation studies of PdeA.

CpdR-ΔN-ClpX did not improve delivery of GFP-PdeA and PdeA when compared
with ClpX and ΔN-ClpX (Figure 2-4B,C). It is plausible that hexameric CpdR-ΔNClpX contain too many CpdR (6) per hexameric ClpX to function normally, so we
mixed CpdR-ΔN-ClpX and ΔN-ClpX in different ratios prior to addition of ATP to
initiate formation of heterogenous complexes. Even though effort to vary the
number of CpdR in a heterogenous oligomer was made, there was no
improvement in delivery (Figure 2-4B).
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Figure 2-4 Fusing CpdR onto ΔN-ClpX did not confer adaptor activity
(A)! Schematic of ClpX, N-ClpX and CpdR- N-ClpX. N-terminal domains (NTD) and
ATPase domains are segmented; ClpX segments in grey; CpdR is in green. Cartoon
of the adaptor-protease fusion is shown.
(B)! Degradation of GFP-ssrA and GFP-PdeA respectively using ClpX,
N-ClpX and
CpdR- N-ClpX in the presence of ClpP. Where indicated, CpdR was added to ClpX
as a control reaction for GFP-PdeA degradation.
N-ClpX and CpdR- N-ClpX
were also mixed in 1:2 and 2:1 ratios. GFP-ssrA degradation rates were used as a
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proxy for active ATPase enzyme activity in the reaction because the concentrations
of unfoldase variants were difficult to assess. Data shown is representative of
experiments done using three independent protein purifications.
(C)! Degradation of PdeA using ClpX, N-ClpX and CpdR- N-ClpX is shown. Note that
ClpP, GTP and ATP regeneration mix is included in all the degradation reactions.

These results suggest that CpdR, on its own, cannot bind to the substrate PdeA,
and perhaps does not contain a substrate-binding domain. At that time, we did
not rule out that the fusion of CpdR onto ΔN-ClpX may have distorted the active
conformation of CpdR. Addition of linkers between CpdR and ΔN-ClpX could
have been helpful. We did test whether PdeA could be degraded by CpdR-ClpX
(CpdR fused directly to the N-terminus of full length ClpX). Generally, the Nterminal domain of ClpX is thought to be floppy, so it could perhaps act as a
flexible linker between ClpX ATPase domain and CpdR in the fusion construct.
However, similar to CpdR-ΔN-ClpX, this CpdR-ClpX fusion construct did not
recover CpdR adaptor activity (data not shown) even though the fusion protein
contained an active unfoldase that can mediate degradation of GFP-ssrA.
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2.3 CpdR does not activate ClpX ATPase rates for adaptor function

CpdR stimulates ATP-hydrolysis rates of ClpX (previously observed by Dr Peter
Chien, reproduced in lab as shown in Figure 2-5B). We considered a known
phenomenon that substrates, particularly folded substrates, activate the ATPase
activity of ClpX due to the need for increased ATP consumption to unfold the
substrates (Burton et al., 2001, 2003; Kenniston et al., 2003). Given that CpdR is
a substrate of ClpXP (Figure 2-5C) (Iniesta and Shapiro, 2008) and contains
folded structures (Appendix 2A(ii)), it is possible that the ATPase rate increase is
due to CpdR being a substrate of ClpXP. We determined whether CpdR could
still activate ClpX ATPase rates if it were forced to not be a substrate of ClpXP.
As shown in (Figure 2-3G (ii), the non-degradable version of CpdR (CpdRDD) is
perfectly functional as an adaptor for delivery of PdeA, and the only change in its
properties is that it cannot be degraded by ClpXP due to mutation of its Cterminal dialanine to diaspartate (Figure 2-3G(i)). It turns out that CpdRDD
cannot activate ClpX ATPase rates (Figure 2-5C).

Not unexpectedly, the substrate PdeA, in conditions that contain all components
for productive delivery (CpdR WT/DD, ClpX(±P), GTP), activated ClpX ATPase
rate (last two column sets in Figure 2-5D). The non-degradable variant of
PdeADD, in similar conditions, did not activate ATPase rates (data not shown).
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Figure 2-5 CpdR does not activate ClpX ATPase rates
(A)! Hypothesizing that CpdR could be modulating ClpX ATPase rates to allow it to
unfold normally folded substrates.
(B)! CpdR WT is added in varying concentrations to ClpX (0.1µM) to assess its impact
on the ATPase rates of ClpX.
(C)! CpdR WT or CpdRDD is added in varying concentrations to ClpX (0.1µM) to
compare their impact on the ATPase rates of ClpX.
(D)! ATPase rates of ClpX (0.1µM) is evaluated in the presence of CpdR WT/DD, PdeA
(GTP added), and in the absence and presence of ClpP.
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We also tested the effects of the absence versus the presence of GTP in the
ATPase activity measurements since GTP enhances the delivery of PdeA (Abel
et al., 2011). GTP addition did not influence ClpX ATPase rates, even if CpdR
WT/DD is present at the same time (data not shown). Therefore, it is likely that
GTP directly modulates PdeA during delivery to ClpXP, consistent with previous
studies showing that GTP binds to PdeA (Christen et al., 2005).

The presence of ClpP suppressed ClpX ATPase activation by CpdR WT, and all
other ATPase reactions (Figure 2-5D). This general suppressive effect of ClpP is
consistent with what is previously observed for E. coli ClpP (Burton et al., 2003).

It is clear from the data (Figure 2-5C,D) that the ATPase rates of ClpX is
activated due the presence of CpdR or adaptor-mediated PdeA as substrates
that are being unfolded and translocated. This is consistent with the
understanding that substrate translocation, particularly for more tightly folded
substrates, require higher ATP consumption (Kenniston et al., 2003). We can
conclude from these ATPase studies that the CpdR adaptor mechanism does not
involve modulating the enzymatic properties of ClpX.
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2.4 CpdR binds to ClpX, thus enabling substrate recruitment ability
2.4.1 Mutations in CpdR impact interaction with both protease and
substrate in the same ranked order
We approached testing of the hypothesis that CpdR is a scaffolding adaptor by
asking whether mutagenesis of the surface residues in CpdR could reveal
mutants that may be deficient in binding the protease or the substrate. We
identified conserved residues in the α4-β5-α5 signaling output face where singledomain response regulators like CheY typically interact with binding partners
(Figure 2-6A). Alanine mutagenesis in the predicted response regulator output
face of CpdR (H104, R106, D107, E111, and K114) revealed two mutations,
H104A (also previously described in Figure 2-3B) and R106A, that impact
delivery of PdeA to ClpXP (Figure 2-6B). CpdRR106A attained wildtype adaptor
activity when added to the reaction at high concentrations, but CpdRH104A does
not recover wildtype activity even when added at high concentrations (Figure
2-6C). Two-hybrid interaction assays indicate that these variants are deficient for
binding to the substrate PdeA and unfoldase ClpX in the same ranked order as
its ability to mediate ClpXP-dependent degradation (Figure 2-6D,E). These
mutants appear to be intact structurally, based on their tertiary folding profile and
ability to be recognized by upstream phosphosignaling cascade (Appendix 2).

We had expected to find mutants that were deficient in interaction with either the
protease or substrate, but instead found mutants that impact interactions with
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ClpX and PdeA simultaneously. The interaction profiles with ClpX and PdeA had
a matching ranked order strength, which was surprising, and was consistent with

Figure 2-6 Mutations in CpdR impact adaptor activity, and interaction with
both protease and substrate, in the same ranked order.
(A)! Phyre homology model (RcsC receiver domain as template) for CpdR. Predicted
α4-β5-α5 signaling output face (yellow), with conserved residues amongst proteobacteria CpdR orthologs (orange).
(B)! Alanine variants of CpdR H104 and R106 were examined for their ability mediate
ClpXP degradation of GFP-PdeA.
(C)! CpdR variants characterized by fitting the initial rates of degradation of GFP-PdeA
as a function of increasing adaptor concentration (Kactivation and Vmax reported),
data plotted as mean
SD; n=4.
(D)! and (E) Two-hybrid interaction between CpdR variants and ClpX/PdeA using E. coli
reporter strains. Representative images on McConkey agar, and beta-galactosidase
( -gal) activity from 4 independent colonies (raw values, mean
SD) are shown.
(F) Suggested models to explain the ranked order interaction data in D and E:
Mutations (*) could be impacting (i) an allosteric site that modulate the binding sites
for interaction with protease and adaptor respectively, or (ii) a surface in CpdR that
is mainly important for interaction with ClpX, but indirectly impacts interaction with
PdeA due to the mediatory influence of endogenous E. coli ClpX.
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the delivery rates. We initially thought that perhaps these mutations impacted an
allosteric site within CpdR that regulates the binding sites of both PdeA and ClpX
(Figure 2-6F(i)). However, another explanation to these BACTH results is that the
endogenous ClpX in the E. coli BACTH reporter strain could be mediating the
interaction between CpdR and PdeA (Figure 2-6F(ii)). Previously, Dr Peter Chien
had tested that the E. coli ClpXP ortholog can degrade PdeA in the presence of
CpdR (Figure 2-7B). If CpdR mutations impact interaction between T25-tagged
CpdR and T18-tagged C. crescentus ClpX, T25-tagged CpdR mutants will also
likely impact interactions with E. coli ClpX. Therefore, indirectly due to the
mediatory effects of E. coli ClpX, T25-tagged CpdR will show a similar deficiency
in interaction with T18-tagged PdeA (Figure 2-6E,F(ii)).

2.4.2 Interaction assays BACTH and size exclusion chromatography reveal
the order of interaction between adaptor, protease and substrate
To characterize the interactions of the CpdR variants using a different method
(Figure 2-6D,E), we set out to measure the adaptor/substrate affinities for CpdR
and PdeA in vitro by size exclusion chromatography (SEC). By SEC, we could
show that the known ClpX adaptor SspB directly binds their substrate prior to
delivery (Figure 2-8E), however, CpdR and PdeA did not form a stable complex
(Figure 2-8A), suggesting that CpdR and PdeA do not strongly interact. This was
surprising because prior work using a bacterial adenylate cyclase two-hybrid
(BACTH) approach suggested that CpdR could directly bind PdeA and ClpX
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(Figure 2-1B) (Duerig et al., 2009; Abel et al., 2011). However, this is also not
totally unexpected because we still have not found convincing evidence that a
substrate-binding domain exists in CpdR. BACTH interaction studies (Figure
2-6D,E) also did not concur with the idea of a simple scaffolding adaptor.

Consistent with the BACTH results, purified CpdR could bind ClpX in solution to
form a stable complex in vitro (Figure 2-8A). We speculated that an endogenous
factor in the Escherichia coli-based two-hybrid assay generated an apparent
positive result between CpdR and PdeA. A natural candidate was ClpX because
the E. coli ClpXP ortholog degrades PdeA in the presence of CpdR (Figure
2-7B). Consistent with this hypothesis, deletion of the E. coli clpX gene
eliminated the apparent BACTH interaction between PdeA and CpdR without
affecting either CpdR/ClpX or PdeA/PdeA interactions (Figure 2-7C), and
introduction of a plasmid expressing the C. crescentus clpX in this ΔclpX
background restores the interaction (Figure 2-7D).

The ATPase-dead ClpX variants clpXE184Q and clpXR367K (protein ATPase
activity tested in vitro, and no activity detected, data not shown) also
complemented the effect of ΔclpX in BACTH reporter strain, E. coli Δcya ΔclpX
(Figure 2-7E). Sequence alignments with E. coli ClpX indicate that C. crescentus
ClpX E184Q is the ATPase mutant equivalent of E. coli ClpX E185Q, which does

42

not hydrolyze ATP, but promotes a ClpX conformation that binds ClpP or ssrAtagged substrates (Hersch et al., 2005), while C. crescentus ClpX R367K is the
ATPase mutant equivalent of E. coli ClpX R370K, which is mutated in the sensor2 motif, preventing ATP hydrolysis, and is locked in an inactive ClpX
conformation unable to bind ClpP or ssrA-tagged substrates (Joshi et al., 2004).
Positive BACTH interaction between CpdR and PdeA in the presence of ClpX
WT, E184Q and R367K indicates that the ternary interaction between CpdR,
PdeA and ClpX is not reliant on ClpX ATP hydrolysis and the (active or inactive)
conformation of the ATPase domain of ClpX.

Our BACTH results (Figure 2-7C-E) suggest that CpdR, ClpX and PdeA together
form a higher order complex in vivo. This was verified in vitro as PdeA clearly comigrated with the CpdR-ClpX complex in the presence of ATPγS, a slowly
hydrolyzed ATP analog, to generate a ternary complex of apparent molecular
weight > 700 kDa (Figure 2-8B). ATPγS promotes formation of stable ClpX
hexamers (Grimaud et al., 1998) without supporting PdeA unfolding for
degradation (Figure 2-8C). In the absence of ATPγS, PdeA did not appear to
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Figure 2-7 Endogenous E. coli ClpX mediates interaction between CpdR
and PdeA in BACTH interaction assays.
(A)! Two models for how endogenous E. coli ClpX could be mediating the interaction
between CpdR and PdeA in BACTH assays.
(B)! CpdR-dependent degradation of PdeA by E. coli ClpXP; results obtained from Dr
Peter Chien now published (Lau et al., 2015). In vitro degradation of PdeA by C.
crescentus and E. coli orthologs of ClpXP when mediated by CpdR in the presence
of ATP and a regeneration system, and 1mM GTP. Samples were examined by
Coomassie staining of SDS-PAGE gel (shown here as greyscale).
(C)! BACTH assay using McConkey agar results in red colonies when interacting
proteins are fused to complementary fragments of adenylate cyclase (cya), T18 and
T25. Fusions of CpdR, PdeA and ClpX (C. crescentus ortholog) examined in E. coli
wild-type and clpX (shaded) reporter strains.
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(D)! Interaction between CpdR and PdeA examined in the
clpX reporter strain
harboring a plasmid expressing C. crescentus ClpX wildtype, or empty plasmid
(pCL1920).
(E)! Interaction between CpdR and PdeA examined in the
clpX reporter strain
harboring a plasmid expressing C. crescentus ClpX wildtype, ATPase-dead mutants
E184Q or R367K, or empty plasmid (pCL1920).

incorporate into a ternary complex (Figure 2-8B), while CpdR still bound ClpX
under these conditions (Figure 2-8A).

We noted that ClpX and PdeA interaction had been detected previously by
BACTH interaction assays (Figure 2-1B) (Abel et al., 2011), and yet PdeA failed
to show strong interaction with ClpX (Figure 2-8B). Previous work had shown that
the N-terminal domain of PdeA is key for CpdR-dependent delivery to ClpX, while
the C-terminus of PdeA was shown to contain a weak degron that is slowly
degraded by ClpX in the absence of CpdR (Rood et al., 2012). We see that PdeA
lacking its C-terminal degron clearly formed a detectable higher-order complex in
the presence of hexameric ClpX and CpdR (Figure 2-8C). This ternary complex
formation indicates that even without the PdeA C-terminal degron, the Nterminus of PdeA allows for CpdR-ClpX-PdeA complex formation, and is
consistent with previous work identifying the N-terminus of PdeA to be key for
CpdR-dependent delivery to ClpX (Rood et al., 2012). An extension from this
result is that even though PdeA C-terminal degron can be weakly recognized by
ClpX (Rood et al., 2012), the C-terminal degron interaction is too weak to
generate a strong binding to ClpX in the SEC assays (Figure 2-8B).
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The model where CpdR and PdeA independently bind to ClpX during the
adaptor-dependent initiation step to form the delivery complex (Figure 2-7B, left)
is not supported due to lack of detectable interaction between PdeA and ClpX
(Figure 2-8B). CpdR interacts with ClpX directly (Figure 2-8A), and formation of
the ternary complex occurs only when all three partners (CpdR, ClpX and PdeA)
are present (Figure 2-8B). This data support a model where CpdR binding to
ClpX creates a recruitment platform for PdeA (Figure 2-7B, right).
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Figure 2-8 Interactions assayed by size exclusion chromatography indicate
that the interaction between adaptor CpdR and unfoldase ClpX enables
recruitment of substrate PdeA.
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(A)! Size exclusion chromatography (SEC) profiles of CpdR (±PdeA/ClpX/ATP S).
Profiles for PdeA (±CpdR) and ClpX (±ATP S). Robust detection of CpdR required
silver staining as it stained poorly by Coomassie (Appendix 3C).
(B)! SEC profiles of PdeA (±CpdR/ClpX/ATP S).
(C)!SEC profiles of PdeA N-terminus (1-265aa) (±CpdR/ClpX/ATP
S). Colored
triangles mark peak locations of individual proteins.
(D)!ATP S cannot support CpdR-mediated ClpXP degradation of PdeA. Degradation
profile of PdeA by ClpXP mediated by CpdR in the presence of ATP or the slowly
hydrolyzed ATP analog, ATP S (5mM). 1mM GTP is present in the reactions.
Temperature of incubation reflects the procedure used for analytical size exclusion
chromatography studies in this work, where samples are incubated 25°C for 20
minutes. Where ATP S is indicated in the studies, samples were incubated with
with 5mM ATP S before injection onto the column at 4°C for 30 minutes elution
time where 1mM ATP S was included in the running buffer.
(E)! Interaction between SspB and GFP-ssrA by SEC. SEC interaction profiles of the C.
crescentus protein orthologs of GFP-ssrA and SspB. Peaks are indicated based on
280 nm measurements during SEC, with single triangles indicating peaks of the
proteins by themselves; double triangles indicating peaks of the proteins when the
adaptor and substrate are mixed.

2.5 Discussion
In this chapter, we examined possible mechanisms that could explain how CpdR
functions as an adaptor utilizing the substrate PdeA to determine how CpdR is
able to deliver substrate to ClpXP (Figure 2-9). We initially hypothesized that
CpdR is a scaffolding adaptor based on previous interaction data performed by
bacterial adenylate cyclase two-hybrid assay (Figure 2-9A) (Abel et al., 2011). To
identify a substrate-binding domain, we used a ClpX-binding-deficient CpdR
variant, CpdRH104A, to test whether we could recover adaptor function when
CpdRH104A is tethered to ClpX using the ClpX-binding (XB)-domain from SspB.
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Figure 2-9 Various models tested to determine the mechanism for CpdR
adaptor
(A) Scaffolding mechanism, (B) ATPase-activating mechanism, (C) ClpX as a scaffold
between CpdR and PdeA, and (D) CpdR binding to ClpX creates an
environment/platform for binding of PdeA.

The results may support that CpdR contains a substrate-binding domain, but the
results could also be explained by an artifact in the system (see Section 2.2 for
detailed explanation). We next tested a direct fusion of CpdR to ClpX (lacking Nterminal domain and full length ClpX), but could not recover adaptor activity. We
also failed to find clear evidence that CpdR contains a substrate-binding domain
during our interaction studies (Figure 2-8A).
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We had hypothesized that CpdR may be able to activate ClpX enzymatic activity
by upregulating ClpX ATPase activity (Figure 2-9B). CpdR activates ClpX
ATPase rates due to its C-terminal dialanine degron causing it to become a
substrate of ClpXP (Figure 2-5C). In contrast, the functional non-degradable
adaptor variant of CpdR could not activate ClpX ATPase rate (Figure 2-5C,D).
We also saw that ATPase-dead mutants of ClpX can complement the
interactions between CpdR and PdeA (Figure 2-7E). Together, these results
leads to our conclusion that ATPase activation is not the necessary criteria for
CpdR to function as an adaptor.

Given the lack of data supporting a scaffolding adaptor model or ATPase
activating model (Figure 2-9 A,B), we carefully performed experiments using size
exclusion chromatography to determine what could be contact points that are
necessary for CpdR to function as an adaptor. We also reexamined the
interactions detected by bacterial adenylate cyclase two-hybrid assay. These
interaction studies taken together indicate that CpdR alone does not bind
strongly to its substrate PdeA (Figure 2-7C and Figure 2-8A). CpdR can,
however, bind to ClpX directly (Figure 2-8A). This again does not support the
model where CpdR acts as a simple scaffold that stably binds both partners
(Figure 2-9A). PdeA on its own does not strongly interact with ClpX (Figure 2-8B)
even though it contains a C-terminal degron that can be weakly recognized by
ClpXP in the absence of CpdR (Rood et al., 2012). The N-terminal region of
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PdeA is sufficient for complex formation between CpdR, ClpX and PdeA (Figure
2-8C). These results indicate that it is unlikely that ClpX directly and separately
binds PdeA and CpdR to generate an adaptor-dependent delivery complex
(model in Figure 2-9C). CpdR binds to ClpX directly (Figure 2-8A), and is key for
the ternary complex formation between CpdR, ClpX and PdeA (Figure 2-8B),
therefore we propose a model where CpdR binds ClpX to allow for subsequent
substrate engagement (Figure 2-9D).
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CHAPTER 3
THE ADAPTOR CPDR PRIMES CLPX N-TERMINAL DOMAIN (NTD) TO
CREATE A RECRUITMENT INTERFACE FOR CARGO

3.1 Introduction – relevance of the N-terminal domain for adaptordependent degradation

The N-terminal domain of AAA+ proteases serves to recognize substrate and act
as an anchor for adaptors (Dougan et al., 2002, 2003; Kirstein et al., 2006).
Findings in Chapter 2 indicate that CpdR interacts primarily with ClpX in order to
activate the ability to create a recruitment platform, therefore we sought to
determine whether the N-terminal domain of ClpX interacts with CpdR. The
scaffolding adaptor SspB, for instance, binds the ssrA peptide and the N-terminal
domain of ClpX (NTDClpX) so as to provide a tether that enhances ssrA substrate
degradation (Wah et al., 2002, 2003; Dougan et al., 2003; Levchenko et al.,
2003). In the following studies, we tested whether CpdR interacts with the Nterminal domain in a manner similar to the scaffolding adaptor SspB.
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3.2 Adaptor-dependent delivery requires the N-terminal domain of ClpX
(NTDClpX)
3.2.1 NTDClpX is necessary for CpdR adaptor function
To determine the importance of the NTDClpX with respect to CpdR function, we
used a variant of ClpX lacking this domain (ΔN-ClpX). Unlike full-length ClpX,
ΔN-ClpX failed to degrade PdeA even in the presence of CpdR (Figure 3-1B).

Figure 3-1 ClpX N-terminal domain is necessary for CpdR adaptor function
(A)! Schematic of ClpX and N-ClpX unfoldases. N-terminal domains (NTD) and
ATPase domains are segmented.
(B)! In vitro degradation of PdeA when mediated by CpdR, comparing ClpXP to NClpXP. Degradation of GFP-ssrA by SspB* was similarly assayed. (C) SEC profiles
of CpdR (±ClpX/ N-ClpX). Profiles of ClpX and N-ClpX alone are also shown.
Profiles were determined by silver staining (brown gels) or Coomassie staining (blue
gels).
nb. SspB* is the non-degradable variant of SspB (Appendix 4A).
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ΔN-ClpX is functional since it degrades GFP-ssrA and as expected does not
support SspB-enhanced degradation (Figure 3-1B) (Dougan et al., 2003).

ΔN-ClpX also failed to bind CpdR in conditions where full-length ClpX forms a
complex with CpdR (Figure 3-1C). We tested whether CpdR could bind NTDClpX
by size exclusion chromatography assay, but could not get consistent formation
of a higher molecular weight complex (data not shown). However, data shown in
Figure 3-1 still indicates that NTDClpX is necessary for the protease adaptor CpdR
to bind the unfoldase ClpX and mediate degradation of PdeA by ClpXP.

3.2.2 Both CpdR and SspB adaptors occupy the N-terminal domain of ClpX
Given the importance of NTDClpX in mediating the adaptor activity of CpdR, we
next tested whether the NTDClpX could compete with full-length ClpX for the
attention of the adaptor. Addition of excess NTDClpX to ClpXP competitively
inhibited CpdR-mediated degradation of GFP-tagged PdeA, and as expected
also inhibited SspB-mediated GFP-ssrA degradation (Figure 3-2A). Addition of
NTDClpX did not significantly affect GFP-ssrA degradation in the absence of
SspB, showing that there is not a general inhibition of ClpXP activity (Figure
3-2A). Consistent with a common need for NTDClpX, the adaptors SspB and
CpdR competitively inhibit each other (Figure 3-2B). It is not certain whether
SspB and CpdR bind to the same contact point on NTDClpX, or cause steric
hindrance to one another.
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3.2.3 NTDClpX is sufficient for CpdR adaptor function
We further observed in BACTH studies that expressing the NTDClpX, similar to
expressing full-length ClpX (Figure 3-7D), is sufficient to restore a positive
bait/prey signal with CpdR and PdeA in a ΔclpX background (Figure 3-3A).

Figure 3-2 SspB and CpdR can compete for ClpX in an NTD-dependent
manner
(A)! NTDClpX fragment addition to the in vitro degradation reactions of substrates GFPPdeA and GFP-ssrA by ClpXP, ± respective adaptors CpdR/SspB*. Data are
represented as mean ± SD, n = 3.
(B)! Competition between the adaptors SspB and CpdR. Left: 0-30µM SspB* was added
to the degradation reaction of GFP-PdeA (1µM) by ClpXP (0.2µM ClpX6, 0.4µM
ClpP14) with CpdRDD (2µM), with 1mM GTP present in the reactions. Right: 0-30µM
CpdRDD was added to the degradation reaction of GFP-ssrA (1µM) by ClpXP
(0.2µM ClpX6, 0.4µM ClpP14) with SspB* (2µM).
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nb. The non-degradable versions of CpdR (CpdRDD) and SspB (residues 11-162,
SspB*) are used in (A,B) to avoid complications that could occur due to trivial
competition of the degradation of the adaptors with the degradation of their cognate
substrates.

Figure 3-3 ClpX N-terminal domain is sufficient for CpdR adaptor function
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(A)! Complementation of the BACTH reporter strain, E. coli cya clpX, by NTDClpX. E.
coli BTH101 clpX ( cya clpX) strains that contained three compatible plasmids:
(1) pKT25-CpdR, (2) pUT18C-PdeA, and (3) pCL1920 empty plasmid or pCL1920
expressing C. crescentus ClpX WT or NTDClpX, were generated. Colonies were
restreaked on McConkey agar containing 1% maltose, 1mM IPTG, 100µg/mL
ampicillin, 50µg/mL kanamycin, and 50µg/mL spectinomycin.
(B)! Schematic of ClpX, ClpA, and chimeric ClpXA unfoldases. N-terminal domains
(NTD) and ATPase domains are segmented; ClpX segments in yellow; ClpA
segments in brown.
(C)! Degradation of GFP-ssrA, PdeA, and PdeA-ssrA (±CpdR) by ClpAP.
(D)! Degradation of PdeA, GFP-ssrA and PdeA-ssrA by the chimeric
ClpXAP±CpdR/SspB*.
In vitro degradation were performed using 0.4µM unfoldases (hexameric), 0.8µM ClpP14
(except for the rapid degradation of GFP-ssrA and PdeA-ssrA by ClpAP, where 0.1µM
ClpA6 and 0.2µM ClpP14 was used) in the presence of 4mM ATP (+ regeneration
system); 2µM adaptors; 1µM substrates; 25µM NTDClpX; 1mM GTP when PdeA (or
variants) is assayed.
nb. SspB* is the non-degradable variant of SspB (Appendix 4A).

Therefore, we asked if the NTDClpX could confer CpdR-dependent delivery of
PdeA in the alternate AAA+ protease ClpAP, which does not normally recognize
PdeA even in the presence of CpdR (Figure 3-2C). We generated a chimeric
unfoldase (ClpXA) by transplanting NTDClpX onto ClpA (Figure 3-2B) and
found that PdeA was not degraded by ClpXAP (ClpXA + ClpP) even in the
presence of CpdR (Figure 3-3D). However, ClpXAP also failed to degrade GFPssrA (Figure 3-3D), a known substrate of both ClpXP (Figure 3-1B) and ClpAP
(Figure 3-3C), reminiscent of prior work showing that modification of the Nterminal regions of ClpA can either enhance or repress delivery of GFPssrA for reasons not completely understood (Lo et al., 2001; Cranz-Mileva et
al., 2008).

Serendipitously, addition of SspB promotes GFP-ssrA degradation by ClpXAP
(Figure 3-3D), suggesting that the NTDClpX in the ClpXA chimera can function
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with its cognate adaptors. We speculated that the PdeA C-terminus may be
poorly recognized by the ClpA unfoldase of ClpXA chimera and that addition of a
known ClpA degron could bypass this defect. In support of this reasoning, PdeA
appended with ssrA (PdeA-ssrA) was degraded by ClpXAP in the presence of
CpdR (Figure 3-3D). SspB also facilitated degradation of PdeA-ssrA (Figure
3-3D). However, CpdR did not improve degradation of GFP-ssrA by ClpXAP
(Figure 3-3D), nor did CpdR stimulate PdeA-ssrA degradation by wildtype ClpAP
(Figure 3-3C).

These data suggest that CpdR enhances specific degradation, rather than
increasing global protease activity upon binding NTDClpX in the ClpXA chimera.
Overall, the results show that the NTDClpX is necessary and sufficient for CpdRdependent degradation of PdeA given suitable substrate engagement by the
associated unfoldase.

3.3 CpdR primes ClpX by binding the N-terminal domain to create a
recruitment interface
3.3.1 CpdR does not behave like the scaffolding adaptor SspB when
artificially tethered to ΔN-ClpX
The scaffolding adaptor SspB adaptor uses the NTDClpX as a simple tethering site
(Dougan et al., 2003; Bolon et al., 2004b; Park et al., 2007; Davis et al., 2009).
As shown schematically in Figure 3-4 (box), if CpdR-dependent degradation also
uses the NTDClpX in a similar manner, it should be possible to bypass the need
58

for the NTDClpX by artificially tethering CpdR to

N-ClpX. However, if the NTDClpX

serves as more than a passive anchor, simply tethering CpdR would not restore
PdeA degradation.
We adopted a previously reported tethering system where human FKBP12
protein is fused to E. coli

N-ClpX, and FKBP12-rapamycin-binding (FRB)

domain of the rat mTOR protein is fused to E. coli SspB (Davis et al., 2009).
Addition of rapamycin induces dimerization of FKBP12 and FRB, tethering SspB
to the

N-ClpX fusion so adaptor function no longer requires NTDClpX (Davis et

al., 2009). We generated Caulobacter orthologs of the FRB-FKBP tethering
system and validated that SspB-FRB could deliver GFP-ssrA-SS (a modified
ssrA-tagged substrate that requires SspB for delivery) to FKBP-

N-ClpX upon

addition of rapamycin (Figure 3-4B). We then examined the characteristics of the
FRB-CpdR fusion.

In contrast to SspB, tethering CpdR to

N-ClpX was insufficient to enhance

PdeA degradation (Figure 3-4B). FRB-CpdR could deliver PdeA to full-length
wildtype ClpXP (Figure 3-4C(i)) and could bind FKBP-

N-ClpX (Figure 3-4C(ii)),

indicating that the FRB-CpdR fusion construct is fully functional. Failure in
delivery when CpdR is tethered to ClpX is reminiscent of the experiments
described in Chapter 2 where CpdR also did not conclusively recover
activity when tethered or directly fused to ClpX (Section 2.2).
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Figure 3-4 Anchoring CpdR is not sufficient to deliver substrates
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Postulated models for NTDClpX as a simple anchoring site for CpdR due to a scaffolding
mode of action (left), or a unique partner in forming a composite recruitment interface for
binding PdeA due to a protease-priming mode of action (right).
(A)! Cartoons illustrate the use of a rapamycin(rap)-induced FRB/FKBP dimer to tether
CpdR or SspB (residues 10-125 that binds ssrA motif) directly to N-ClpX. GFPssrA-SS (requires SspB for delivery) degradation by FKBP- N-ClpXP when
mediated by SspB-FRB. PdeA levels in the presence of FRB-CpdR/FKBP- NClpXP/rap (detected by Western using α-PdeA due to overlapping bands).
(B)! Characteristics of the FRB-CpdR protein:
(i)! The CpdR portion of FRB-CpdR can mediate degradation of PdeA by ClpXP: In
vitro degradation of PdeA (1µM) by ClpXP (0.4µM ClpX6, 0.8µM ClpP14)
mediated by CpdR/FRB-CpdR (2µM). The results indicate that FRB-CpdR is
less active than CpdR WT but retains adaptor functionality.
(ii)! The FRB portion of FRB-CpdR can bind FKBP: Assay to check whether FRBCpdR competes with SspB-FRB-mediated delivery, indicating FRB-CpdR binds
FKBP- N-ClpX in the presence of rapamycin. Cartoon shows SspB-FRBdependent delivery of GFP-ssrA-SS to FKBP- N-ClpXP in the presence of
rapamycin. FRB-CpdR was added to see if it could compete with SspB-FRB for
binding to FKBP- N-ClpX. Initial rates of degradation of GFP-ssrA-SS (1.5µM)
mediated by 1µM SspB-FRB/0.4µM FKBPN-ClpX6/0.8µM ClpP14/10µM
rapamycin in the presence of increasing concentrations of FRB-appended
CpdRs are shown on the right.

3.3.2 The substrate simply needs an anchorage point for delivery to ClpXP
We next asked if the substrate really does simply require an anchorage point to
ClpX for delivery. If provision of an anchorage point does not recover
degradation, it will mean that a more complex mode of delivery is needed to
deliver PdeA. We appended an SspB-derived peptide motif that binds to the
NTDClpX (also known as the ClpX-binding domain, XB) to the N-terminus of PdeA.
This XB-PdeA fusion was robustly degraded even in the absence of CpdR
(Figure 3-5A). Degradation of XB-PdeA by ClpXP increases in the presence of
CpdR (Figure 3-5A), probably due to provision of two modes of access to ClpX
(XB and CpdR).

61

Replacing the C-terminal residues of XB-PdeA protein with di-aspartate residues
(XB-PdeA-DD) blocked degradation, indicating that the degradation occurs from
the C-terminus similar to PdeA and that the XB motif does not simply act as a
degradation tag (Figure 3-5A).

Finally, the PdeA R69A variant (which is poorly delivered by CpdR to ClpXP
(Rood et al., 2012)) can be degraded when the XB motif is appended (Figure
3-5A). XB-PdeAR69A degradation by ClpXP is not affected by the presence of
CpdR, validating that the need for CpdR can be bypassed when PdeA is tethered
to ClpX.

We next asked if the NTDClpX was dispensible for degradation of PdeA tethered
directly to ClpX. We produced a FRB-PdeA construct and found that this
substrate was degraded in a rapamycin specific manner by FKBP-ΔN-ClpX
(Figure 3-5B). Mutation of the C-terminal residues to di-aspartate residues
blocks degradation even in the presence of rapamycin (Figure 3-5B). This
indicates that both NTDClpX and CpdR is dispensable for PdeA delivery if an
alternative anchor point is provided.
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Figure 3-5 Adaptor dependence can be bypassed through direct
attachment of substrate to ClpXP
(A)! The ClpX binding motif from SspB (XB) is appended to PdeA N-terminus to create
XB-PdeA. Degradation of XB-PdeA (±CpdR), XB-PdeADD (where the C-terminal
residues is mutated to Asp-Asp), and XB-PdeAR69A (±CpdR) by ClpXP is
examined. PdeAR69A is a variant of PdeA mutated in its N-terminus that is not
degraded by ClpXP in the presence of CpdR (Rood et al., 2012).
(B)! PdeA levels when directly tethered to N-ClpX via the FRB/FKBP dimer system.
FRB-PdeA C-terminus Arg-Gly is mutated to Asp-Asp to create FRB-PdeADD.
Protein bands detected by Coomassie staining.
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In these experiments, the rate of delivery of PdeA is slower when using the XBtag compared to the FRB/FKBP dimer system. One difference between the
system is in the protease construct, where native ClpX contains NTDClpX while
FKBP-ΔN-ClpX lacks NTDClpX. It is tempting to think that NTDClpX slows the
presentation of PdeA to the ATPase pore of ClpX. However, there are other
differences between the tethering systems that need to be accounted for as well
such as the binding strength according to different tethering system and the
possible differences in positioning of the substrate due to the different tethering
system.

Fundamentally, these results show that directly tethering PdeA to ClpX is
sufficient to bypass the need for both CpdR and the ClpX N-terminal domain.
These results are consistent with our emerging model that interactions between
CpdR and the NTDClpX generates a tethering site for PdeA, which is engaged by
ClpX via its C-terminal degron.

3.3.3 CpdR primes ClpX through NTDClpX to create an anchorage point
Results from the previous section indicates that the substrate PdeA simply
requires an anchorage point for delivery to the ATPase pore of ClpX (Figure
3-5B). If our priming model is correct (Figure 3-4, right), then the NTDClpX acts as
more than a passive docking site and binding of CpdR to NTDClpX is explicitly
needed for PdeA recognition. Consistent with this hypothesis, addition of
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CpdR binding to the ClpX N-terminal domain forms a
Figure 3-6
recruitment interface
(A)! Impact of NTDClpX on PdeA levels in the presence of FRB-CpdR/FKBP-ΔNClpXP/rap (detected by -PdeA Western blot). We monitored delivery of 1µM
substrate GFP-PdeA to 0.4µM FKBP-ΔN-ClpX6/0.8µM ClpP14/10µM rapamycin with
3µM FRB-CpdR in the absence and presence of 25µM NTDClpX fragment.
(B)! Effect of NTDClpX fragment concentration on the delivery of GFP-PdeA to FRBCpdR/FKBP-ΔN-ClpXP (rapamycin added). Apparent Kactivation is shown, see
Methods. Mean ± SD, n = 3 experiments.
(C)!Effect of NTDClpX on delivery of GFP-ssrA-SS by adaptors SspB-FRB/FRB-CpdR
when tethered to FKBP-ΔN-ClpXP. We monitored delivery of 1µM substrate GFPssrA-SS to 0.4µM FKBP-ΔN-ClpX6/0.8µM ClpP14/10µM rapamycin with 3µM SspBFRB/FRB-CpdR in the absence and presence of 25µM NTDClpX fragment. mean ±
SD, n = 3 experiments.

NTDClpX to reactions where FRB-CpdR is tethered to FKBP-ΔN-ClpX restored
degradation of PdeA (Figure 3-6A). Increasing concentrations of NTDClpX
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increased substrate delivery of a GFP-PdeA reporter with an apparent Kactivation of
8.2 ± 0.6 µM (Figure 3-6B). The effect of NTDClpX addition is not due to a general
increase in protease activity as addition of NTDClpX had no effect on GFP-ssrASS degradation (Figure 3-6C). These results clearly show that CpdR does not
use the NTDClpX as a simple tethering site. Rather, CpdR binding to NTDClpX is
specifically necessary to prepare ClpX to engage PdeA.

3.4 Priming adaptors are resistant to inhibitory effects seen with
scaffolding adaptors
Because general adaptor mechanisms may have different consequences, we
considered how scaffolding and priming adaptors function at various adaptor
concentrations. Scaffolds are often signal pathway components, with an optimal
concentration of scaffold improving signal transduction, but excess scaffold
reduce signal flux by titrating partner proteins away from one another (for
examples, see Good et al., 2011). Similarly, as illustrated in (Figure 3-7A) high
concentrations of a scaffolding adaptor like SspB should reduce substrate
delivery due to formation of complexes that do not contain both binding partners
(i.e., complexes that contain adaptor/substrate only or adaptor/protease only). In
contrast, excess concentrations of a priming adaptor like CpdR should show no
inhibitory effect if substrates only engage a primed protease.

We tested our prediction by measuring substrate delivery by SspB and CpdR
under conditions of excess adaptor, using substrates (GFP-ssrA-SS and GFP-

66

PdeA) that are poorly recognized by ClpXP in the absence of their adaptors. To
avoid concerns that the adaptors could compete with their substrates for
degradation by ClpXP, and inhibit substrate delivery for this trivial reason, we
utilized the non-degradable functional versions of these adaptors, SspB*
(Appendix 4A) (Chien et al., 2007b) and CpdRDD (Figure 3-3G). At low
concentrations, both adaptors effectively delivered their respective substrates,
but high concentrations of SspB* inhibited delivery of GFP-ssrA-SS (Figure 3-7B;
Appendix 4E). In contrast, excess CpdRDD did not suppress degradation of
GFP-PdeA (Figure 3-7C; Appendix 4F).

Scaffolds are also sensitive to inhibition due to changes that eliminate one of the
partner binding sites. Indeed, the substrate binding domain (SBD) of SspB is
sufficient for ssrA binding but lacks the ClpX binding motif (Dougan et al., 2003;
Bolon et al., 2004b; Park et al., 2007; Davis et al., 2009). Addition of the SspB
SBD strongly inhibited ssrA degradation even in the presence of full length
adaptor (Figure 3-8A) Overexpression of the SspB SBD in vivo also stabilized an
ssrA-tagged substrate even in the presence of wildtype SspB (Figure 3-8C and
Appendix 4G). In contrast, excess concentrations of the ClpX binding deficient
CpdRH104ADD did not inhibit CpdR-mediated degradation of GFP-PdeA (Figure
3-8B) and overexpression of this variant in vivo did not stabilize PdeA in the
presence of wildtype CpdR (Figure 3-8D and Appendix 4I).
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Figure 3-7 Adaptor effects at excess concentrations
(A)! Predicted changes in substrate delivery due to concentrations of a scaffolding
adaptor or protease priming adaptor: Excess scaffolding adaptor inhibits substrate
delivery due to formation of substrate-adaptor and protease-adaptor complexes.
Excess protease priming adaptor does not inhibit delivery.
Degradation by ClpXP in vitro in the presence of varying adaptor concentrations were
assayed as follows:
(B)! GFP-ssrA-SS (an SspB-obligate substrate) using adaptor SspB*.
(C)!GFP-PdeA (a CpdR-obligate substrate) using adaptor CpdRDD.
In vitro degradation performed using 0.4µM ClpX6, 0.8µM ClpP14 in the presence of 4mM
ATP (+regeneration system); 1µM substrates; (D,F) contained 1µM SspB*/CpdRDD; and
1mM GTP when GFP-PdeA is assayed.
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nb. non-degradable adaptor variants (SspB* and CpdRDD) are used throughout to avoid
trivial competition between adaptor and cargo substrates (Appendix 4E,F). Data
represented as mean ± SD, n = 3 experiments.

Figure 3-8 Impact of overexpressing the protease-binding deficient
variants of the adaptors CpdR and SspB in vivo
We examined the adaptor abilities of SspB and CpdR in the presence of their proteasebinding-deficient variants. Degradation by ClpXP in vitro were assayed as follows:
(A)! GFP-ssrA-SS (an SspB-obligate substrate) using the substrate-binding domain
(SBD) of SspB in the presence of wildtype-like SspB*.
(B)! GFP-PdeA using the ClpX-binding deficient adaptor variant CpdRH104ADD in the
presence of wildtype-like CpdRDD.
For (B) and (C), the x-axis is the ratio of mutant adaptor relative to wildtype-like adaptor.
Wildtype-like adaptors are the non-degradable adaptor variants (SspB* and CpdRDD)
used to avoid trivial competition between adaptor and cargo substrates (Appendix 4E,F).
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The protease-binding deficient adaptors are overexpressed in C. crescentus cells that
contain wildtype SspB and CpdR as follows:
(C)! Effect of SspB (SBD) on levels of GFP-ssrA-SS in vivo. FLAG-tagged GFP-ssrASS reporter (detected by α-GFP) is integrated at the chromosomal vanA locus and
expressed by addition of 1mM vanillate. SspB (SBD) is expressed from a high-copy
plasmid JS14 (induced by addition of 0.2% xylose, detected by α-FLAG). Results
are compared with expression of Flag-GFP-ssrA-SS in sspB strain.
(D)! Effect of CpdRH104ADD on PdeA levels in vivo. Similar to (F), FLAG-tagged PdeA
reporter is chromosomally integrated for vanillate-induced expression, and FLAGtagged CpdRH104ADD is expressed from the plasmid JS14 (both detected by αFLAG). Results are compared with expression of Flag-PdeA in cpdR strain.
Cells in (C&D) were induced at exponential phase (OD600<1) for four hours before
harvesting for Western blots. (B-G) performed in triplicates. See also Appendix 4G, I.

3.5 Discussion
In the beginning of Chapter 3, the experimental studies indicated that SspB and
CpdR behave similarly. Both require the use of the N-terminal domain of ClpX for
adaptor function (Figure 3-1). SspB and CpdR can even compete in ClpXPdependent degradation (Figure 3-2B), however, we have yet to examine whether
this is truly the case in vivo.

Surprisingly, unlike SspB, CpdR does not just use NTDClpX to anchor onto ClpX,
and instead interacts in a specific manner NTDClpX to activate the creation of
a recruitment site for PdeA (Section 3.3). It is still a mystery how this happens.
Perhaps CpdR and NTDClpX both contain weak binding sites for PdeA, but
together are sufficient to anchor PdeA. Alternatively, NTDClpX and
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Figure 3-9 Model of the protease-priming mechanism
(A)! The primed complex consisting of CpdR and NTDClpX recruits the substrate PdeA for
degradation. The priming mechanism is insensitive to inhibition due to excess
unfulfilled adaptors.
(B)! CpdR and NTDClpX could both be contributing individual weak interactions to
promote cargo recruitment (i), or binding could be inducing conformational changes
to promote cargo recruitment (ii).

CpdR may induce conformational change in one another, resulting in a display of
contact points that provide a recruitment site. The hexameric state of ClpX as an
unfoldase may also play a role in modulating binding of CpdR to ClpX, or
contribute to create a more intricate platform for recruitment.

The lack of an independent substrate-binding domain (based on studies in
Chapter 2) and the ability to recruit substrate only upon binding to ClpX through

71

the NTDClpX (Figure 3-8 and Figure 3-6) are two key evidences that indicate
that CpdR is a protease-centered adaptor. The final evidence that supports
this protease-priming mechanism was found based on our prediction and finding
that a protease-priming mechanism should be resistant to the inhibitory effects
that affect scaffolds at high concentrations (Figure 3-7A).
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CHAPTER 4
PHOSPHOSIGNALING MODULATES CLPX PRIMING

4.1 Introduction – role of phosphorylation during Caulobacter cell cycle
C. crescentus is a bacterium evolutionarily evolved to occupy oligotrophic niches
in the environment. Multiple proteins that are normally important to maintain G1
phase/swarmer cell function are modulated when cells detect low levels of
nutrient. These changes allow the cell enter its replicative state, taking this
opportunity to multiply. The decision to transition through the cell cycle occurs
through an important phosphosignaling pathway (previously illustrated in Chapter
1, Figure 1-4). This phosphosignaling pathway influences genome replication,
and broad-spectrum programs for transcription and proteolysis through its two
effectors, CtrA and CpdR.

CtrA is a DNA-binding response regulator protein. Its N-terminal receiver domain
receives phosphorylation signals in order to modulate the function of its Cterminal DNA-binding domain. DNA replication is silenced during the G1 phase of
the cell cycle because CtrA occupies the origin of replication (oriC). CtrA is also a
transcription regulator, influencing at least 95 genes through its ability to induce
or repress gene expression throughout the cell cycle, and these genes are
involved in DNA replication, DNA methylation, cell division and differentiation
(Laub et al., 2002).
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In contrast to CtrA, CpdR is a single-domain response regulator protein that
contains a receiver domain that receives phosphorylation signals, but has no
clear effector domain. It is known that the phosphorylation status of CpdR
influences its ability to modulate ClpXP-dependent degradation of multiple
substrates with diverse functions; for instance CtrA itself is a substrate that is
dependent on CpdR; PdeA, a phosphodiesterase; McpA, a chemoreceptor,
TacA, a response regulator that modulate stalk biogenesis, and many more
some of which its function is not yet quite understood.

During the swarmer to stalked cell transition (G1-S), CpdR dephosphorylation
modulates ClpX localization to the stalked pole so that its co-located substrates
are degraded rapidly (Iniesta et al., 2006). In recent years, it has become
established that CpdR is an adaptor that cooperates with other adaptors to
deliver a broad range of substrates (Figure 1-6). In vitro experiments show that
CpdR phosphorylation prevents delivery of substrates. Dephosphorylation (or
unphosphorylated CpdR) activates degradation of specific proteins by ClpXP.

In this chapter, we explore how phosphorylation modulates the adaptor function
of CpdR. If CpdR is a scaffolding adaptor, one can think that phosphorylation
could modulate CpdR binding to its substrate, similar to how phosphorylation
modulates binding of the adaptor RssB to its substrate RpoS (Hengge, 2009).
Since we have established that CpdR must interact with ClpX in order to create a
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recruitment platform (Chapter 2 and 3), we asked whether phosphorylation gates
(1) binding to ClpX, (2) formation of a recruitment platform (i.e. binding to ClpX is
not influenced by phosphorylation), or perhaps (3) an unknown catalytic event
that negates CpdR adaptor activity. We approach the mechanistic role of CpdR
phosphorylation through interaction studies and mutagenesis studies as follows.

4.2 Phosphorylation modulates CpdR binding to ClpX, providing the first
and key step in regulating ClpX recruitment ability during cell cycle

ClpXP-mediated protein degradation during the Caulobacter cell cycle depends
on CpdR phosphorylation (Iniesta et al., 2006), where multiple components
control the hybrid histidine kinase CckA that transfers phosphate via the
phosphotransferase ChpT onto Asp51 of CpdR (Figure 1-4) (Biondi et al., 2006b;
Iniesta et al., 2006). Phosphorylation of CpdR inhibits degradation of PdeA (Abel
et al., 2011) (Figure 4A), so we set out to determine how phosphorylation of
CpdR modulates the recruitment of PdeA.

We find that phosphorylation of CpdR disrupted binding to ClpX (Figure 4-1B).
This disruption relied on ATP and Asp51 of CpdR, verifying that active
phosphorylation was needed to prevent ClpX binding (Figure 4-1B). Importantly,
CpdR phosphorylation also prevented formation of the higher molecular weight
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PdeA/CpdR/ClpX complex (Figure 4-1C). This shows that loss of priming of ClpX
upon phosphorylation of CpdR results in loss of substrate engagement.

In Chapter 3, we had shown that CpdR uses the N-terminal domain of ClpX to
form a recruitment interface. Artificial tethering experiments had shown that a
CpdR fusion protein (FRB-CpdR) tethered to ΔN-ClpX (FKBP ΔN-ClpX) delivers
substrate PdeA only if NTDClpX fragment is added (Figure 3-6). This had indicated
that CpdR primes ClpX through NTDClpX to create the ability to recruit PdeA.
Using this same setup, we find that pre-phosphorylating CpdR prevents delivery
of GFP-tagged PdeA (Figure 4-1D). CpdR binds full-length ClpX in a
phosphorylation-dependent manner (Figure 4-1B), therefore this indicates that
phosphorylation gates CpdR binding to the N-terminal domain of ClpX to
modulate the protease-priming mechanism (Figure 4-1D cartoon).
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Figure 4-1
NTDClpX

Phosphorylation modulates CpdR binding to ClpX through

(A)! Effect of phosphorylation by the cognate CckA/ChpT phosphorelay on wildtype
CpdR (WT) or the non-phosphorylatable variant CpdRD51A in mediating PdeA
delivery to ClpXP. CpdR WT and CpdRD51A proteins were preincubated with the
phosphorelay. PdeA detected by Western using -PdeA due to overlapping bands.
(B)! SEC profiles of CpdR WT/ CpdRD51A (±phosphorelay/ATP/ClpX).
(C)! SEC profiles of PdeA (detected by Western using -PdeA) in the presence of CpdR
WT/D51A (preincubated with phosphorelay/ATP) and ClpX/ATP S.
(D)! Effect of phosphorylation on the NTDClpX-dependent delivery of GFP-PdeA to FRBCpdR/FKBP- N-ClpXP (rapamycin added). FRB-CpdR phosphorylated using its
cognate phosphorelay CckA/ChpT by preincubation with 1.5µM CckA-HK, 0.75µM
CckA-RD, 0.5µM ChpT, and 5mM ATP for 40 minutes. In vitro degradation
performed using 0.4µM FKBP- N-ClpX6, 0.8µM ClpP14 in the presence of 4mM
ATP and a regeneration system.
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4.3 CpdR signaling output face is key for binding to ClpX
4.3.1 Modifying the CpdR output face impacts its ability to deliver substrate
Phosphorylation often affects the function of response regulator receiver domains
through conformational changes that are allosterically communicated to their
conserved 'signaling output face' comprised of the α4-β5-α5 surface (Gao and
Stock, 2010). As previously described in Chapter 2, CpdR homology modeling
using Phyre (Kelley and Sternberg, 2009) revealed a topology similar to singledomain response regulators (Figure 4-3) (Bourret, 2010). We had mutated
several conserved surface residues in the signaling output face (H104, R106,
D107, E111, and K114) to alanine (Figure 4-2) and identified two variants that
were defective in enhancing PdeA degradation (shown here again in Figure
4-3B,C). Both variants were properly folded based on proper recognition by the
CckA/ChpT phosphorelay (Figure 4-3G). Although both variants were defective in
mediating PdeA degradation, the R106A variant achieved wildtype activity at
saturating adaptor concentrations while the H104A variant did not achieve
wildtype activity (Figure 4-3C). These mutations inhibited the interaction between
CpdR and ClpX in vitro (Figure 4-3D) reducing assembly of a CpdR/ClpX/PdeA
complex as assessed by BACTH (Figure 4-4E) in the same ranked order as the
loss in PdeA degradation (Figure 4-3B,C). Similar changes in activity were seen
with the chimeric ClpXAP (Figure 4-3F), supporting the important role of CpdR
signaling ouput face in binding to NTDClpX. Whether CpdR residues H104 and
R106 are involved in conformational changes that affect binding to ClpX or if they
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directly constitute the interface that binds ClpX cannot be distinguished at this
point.

Figure 4-2 Location of CpdR residues that were mutated to alanine
A schematic was drawn based on the homology model of CpdR generated using Phyre
(Figure 4-3A). H104, R106, D107, E111 and K114 are conserved charged residues
were that selected for alanine mutagenesis H104 is predicted to locate in the 5- 5
loop, while R106, D107, E111, and K114 are predicted to locate in the 5 helix.
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Figure 4-3 Mutations in CpdR output face, R106A and H104A, impact
adaptor activity and interaction with ClpX
(A)! Phyre homology model (RcsC receiver domain as template) for CpdR. Predicted
α4-β5-α5 signaling output face (yellow), with conserved residues amongst proteobacteria CpdR orthologs (orange).
(B)! Alanine variants of CpdR H104 and R106 of CpdR (1.5µM) were examined for their
ability to mediate ClpXP (0.4 ClpX6, 0.8µM ClpP14) degradation of GFP-PdeA
(1µM).
(C)! CpdR variants characterized by fitting the initial rates of degradation of GFP-PdeA
(1µM) as a function of increasing adaptor concentration (Kactivation and Vmax reported;
see Methods), data plotted as mean ± SD, n = 4.
(D)! SEC profiles of the CpdR variants (±ClpX).
(E)! Two-hybrid interactions between CpdR variants and ClpX/PdeA using E. coli cya
reporter strains. Representative images on McConkey agar, and beta-galactosidase
( -gal) activity from 4 independent colonies (raw values, mean ± SD) are shown.
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(F)! In vitro degradation of 1µM PdeA-ssrA by the chimeric ClpXAP (0.4µM ClpXA6,
0.8µM ClpP14) when mediated by CpdR WT/ R106A/H104A variants (2µM).
For (B,C&G), 20µM CpdR/5µM ClpX6/5µM PdeA/1mM ATP S, and 1mM GTP when
PdeA is assayed. In (B&C), CpdR was preincubated with final concentration 10µM
CckA-HK, 5µM CckA-RD, 5µM ChpT, and 5mM ATP for 40 minutes. SEC experiments
were performed independently at least twice; colored triangles mark peak locations of
individual proteins.
Note: Figure 4-3 B,C, and E were previously shown as Figure 2-6 B,C,D, and E.

R106A and H104A mutations do not appear to affect CpdR ability to be
phosphorylated (Figure 4-3G). CckA-RD and CckA-HK used in the experiments
are an artificially split construct of the original CckA histidine kinase that enforces
the kinase mode and minimize its phosphatase mode (Chen et al., 2009). This
test, using CckA (CckA-HK and RD) preloaded with ATP prior to addition to ChpT
and CpdR, indicates that similar to wildtype CpdR, the R106A and H104A
variants are phosphorylated at a very quick rate based on their band intensity
after 5 minutes incubation. Phosphorylation also impairs the ability of these CpdR
variants from delivering PdeA (data not shown). If there are any differences in the
phosphorylation rates of these variants, these differences may need to be teased
apart by slowing down the rates of phosphorylation, perhaps by reducing the
temperature of the incubation. Taken together, these data indicate that mutating
R106 and H104 to alanine mainly affects binding to ClpX.

4.3.2 Modifying the CpdR output face impacts its biological activity
The CpdR signaling output face variants (Figure 4-3) provide the opportunity to
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tune ClpX binding in vivo and determine the biological consequences of altering
the interaction between CpdR and ClpX. CpdR activity must be properly
controlled in vivo. For example, both absence of CpdR and overproduction of the
constitutively active unphosphorylatable CpdRD51A variant yield reduced colony
sizes on soft agar plates (a combined outcome of changes in motility,
chemotaxis, and growth) (Figure 4-4A,B) (Skerker et al., 2005; Iniesta et al.,
2006). Strains expressing WT, R106A or H104A variants as their sole copies of
CpdR produced colony sizes that followed the same rank order as their ability to
deliver PdeA in vitro (Figure 4-4A). Similarly, overexpressing CpdRD51A variants
carrying these point mutations reduced colony sizes in the same ranked order
(Figure 4-4B).

We also tested these CpdRD51A variants in ΔpdeA strains, which form smaller
colonies than wildtype C. crescentus (Rood et al., 2012), and again observed
effects in colony sizes with respect to CpdR variants (Figure 4-4C). Because
CpdR influences the cell-cycle dependent degradation of proteins beyond PdeA
(Iniesta et al., 2006; Radhakrishnan et al., 2010; Bhat et al., 2013), these results
suggest that additional ClpXP substrates are reliant on the same CpdR priming
of ClpX as PdeA.
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Figure 4-4 CpdR signaling output face is important for its biological activity

Effects of CpdR output face variants (H104A and R106A) examined by soft agar colony
assay. CpdR variants expressed using xylose-inducible plasmids in C. crescentus (A)
cpdR, (B) wildtype, and (C) pdeA strains were examined by colony stabbings on soft
agar (PYE 0.3% agar, respective antibiotics, and 0.2% xylose as inducer).
Representative images of colonies are shown, and colony area (mean ± SD, n=8)
normalized to the strain carrying the GFP-expressing control plasmid are shown.
(D) Effects of CpdR variants on ClpX localization in C. crescentus. Xylose-inducible
plasmids harboring CpdR variants were expressed in C. crescentus cpdR Xylprom-clpXgfp. Cells were examined after exponential growth (OD600<1) in PYE media (0.2%xylose
as inducer, 25µg/mL spectinomycin) for 6 hours. Unsynchronized cells were imaged on
agar pads (containing PYE and 0.2% xylose) by phase contrast and fluorescence
microscopy (scale bar correspond to 2µm). ClpX foci intensities from 700 cells of each
unsynchronized strain were analyzed using MicrobeTracker, and presented by histogram.
See Appendix 5 for the expression levels of these CpdR variants on plasmids.
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Previous studies suggested that CpdR-dependent degradation in vivo was due to
CpdR-dependent recruitment of ClpX to the incipient stalked pole of C.
crescentus where substrates also transiently localize (Iniesta et al., 2006;
McGrath et al., 2006). We found that loss in ClpX-GFP localization in ΔcpdR
strains (Iniesta et al., 2006) could be overcome by expression of the R106A
variant of CpdR, although with less intense foci (Figure 4-4D), while expression
of the H104A variant resulted in diffuse localization of ClpX (Figure 4-4D) similar
to that seen in the ΔcpdR strain (Iniesta et al., 2006). The results indicate that
CpdR binding to ClpX is directly correlated with ClpX localization; however, it
remains unclear if substrate degradation in vivo specifically requires the
localization of ClpXP.

4.4 Search for suppressors of CpdRH104A yields an activated CpdR variant
that is resistant to phosphorylation

The mutagenesis studies of the output face of CpdR yielded CpdRR106A and
CpdRH104A variants that are defective for binding to ClpX. We are uncertain
whether these mutations (1) directly impacts a ClpX-binding site, or (2) indirectly
impacts an actual ClpX-binding site through conformational changes that affect
the binding site. Cross-linking experiments, or structural determination by protein
crystallography or nuclear magnetic resonance (NMR) may be the most
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appropriate way to approach this question. We had some difficulties with that
approach and halted the attempts at that time.

Here, we describe a suppressor mutant screen to identify intramolecular
mutations that could recover defects due to either the R106A or H104A
mutations in CpdR. Our predictions are that (1) Mutations near R106 or H104
that recover activity may indicate that the R106 or H104 residue is a direct ClpXbinding site. (2) Mutations that occur far away from the original site of mutation
(i.e. far away from R106 and H104) indicate that compensatory conformation
changes were needed to recover activity. This supports the idea that CpdR is a
dynamic protein that can undergo conformational shifts.

Special mention to Ying Zhi Zhang, an undergraduate student in the Chien Lab,
who spearheaded the screening efforts to find intramolecular suppressor
mutations for the H104A and R106A CpdR variants. Ying developed an errorprone PCR approach by doping manganese into the PCR amplification reaction
(Lingoerke, 1997). CpdRH104A DNA fragment was used as template, and the
DNA fragments obtained by error-prone PCR were digested and ligated in-frame
into a BACTH plasmid to create T25-CpdR. The ligated pool of plasmids were
transformed into BACTH reporter strains that contain either T18-ClpX or T18PdeA as ‘bait’ proteins. The ‘preys’ were identified based on their ability to
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recover any red coloration. Intact T25-CpdRH104A or truncated CpdR protein
due to incorporation of stop codons within CpdR ought to show no red coloration.

Interestingly, the screen resulted in three different suppressor mutants that
shared mutations in Asp9 residue (Figure 4-5A). A quadruple mutant
variant, CpdR D9G D11E K97R H104A, found from the T18-ClpX screen
interacts with ClpX only, and not PdeA. The triple mutants, CpdR D9G
S100F H104A and CpdR D9N V103M H104A, found from the T18-PdeA
screen interact with both ClpX and PdeA. Qualitatively, CpdR D9G S100F
H104A appeared to be the best contender for recovery of interaction with its
partners (Figure 4-5A), so this mutant was selected for detailed studies in vitro.
Since CpdR D9G S100F H104A was discovered based on the T18-PdeA bait,
we also selected the quadruple mutant discovered from the T18-ClpX bait for
detailed studies in vitro (Figure 4-5A).

We purified the suppressor mutants proteins, CpdR D9G S100F H104A and
CpdR D9G D11E K97R H104A, for studies in vitro, testing their ability to mediate
delivery of GFP-PdeA by ClpXP. The mutant with strongest interaction by
BACTH, CpdR D9G S100F H104A, did not improve delivery GFP-PdeA for
degradation by ClpXP when compared to the parental CpdR H104A protein
(Figure 4-5B). It was confusing why the D9G S100F mutation did not give rise to
better delivery. Instead, the quadruple mutant improved CpdRH104A adaptor
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Figure 4-5 BACTH suppressor screen for CpdRH104A repetitively yield
mutations in the D9 position
(A)! Random mutagenesis on a CpdRH104A DNA fragment prior to ligation into a
pKT25 backbone created a pool of T25-mutagenized CpdRH104A plasmids that
could be screened for gain-of-function in BACTH interaction studies using a bait,
T18-ClpX or T18-PdeA, and the reporter strain, E. coli cya. Plasmids in colonies
that were redder when examined by eye on McConkey agar were harvested for
sequencing. Three of the red colonies shared mutations at the D9 residue, even
though sourced from different baits, T18-ClpX and T18-PdeA. These colonies are
shown here in side-by-side McConkey agar assays. Cell droplets of equal density
on the agar were incubated at 37 °C overnight for growth, and imaged after 6 days
at room temperature. Data from Ying Zhi Zhang.
(B)! Two suppressor mutants, CpdR D9G D11E K97R H104A and CpdR D9G S100F
H104A, were cloned into pET23-His-SUMO plasmids for protein purification. These
proteins were examined for ability to regain adaptor function, when compared to the
parental H104A, using GFP-PdeA degradation by ClpXP (1mM GTP and ATP
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regeneration mix included). Wildtype (WT) CpdR is also used as a control in the
side-by-side studies. Data reproducing Ying Zhi Zhang’s results.
(C)! Mutations in CpdR D9G D11E K97R H104A were parsed apart. D9G versus D11E
K97R mutations were examined in CpdR H104A. Adaptor activity for CpdR WT,
H104A and the original D9G D11E K97R H104A variant are shown in the side-byside study.
Note: There are differences in activity for the quadruple mutant CpdR D9G D11E K97R
H104A in Figure 4-5 B and C, and we attribute this to batch-to-batch variation in
preparations (for example wildtype CpdR proteins prepared from the same time period is
more similar than from different time periods, and we have not identified the cause for
this). CpdR variant proteins in Figure 4-5 B were prepared by Ying Zhi Zhang. CpdR
Figure 4-5 C were prepared by Joanne Lau.

activity (Figure 4-5B), so we performed site-directed mutagenesis to determine
which mutation is key for recovery in adaptor activity. It turns out that the D9G
mutation was sufficient for recovering the activity of the quadruple mutant, while
the D11E K97R mutations were dispensable (Figure 4-5C).

We mapped the D9 residues in CpdR to a CheY structure and observed an
overlap between D9 and CheY residues D12/13 (Figure 4-6A, circle). The D12
and D13 residues in CheY are known to coordinate Mg2+ binding (Bellsolell et al.,
1994). In CheY, Mg2+ binding is necessary for phosphorylation, and so mutating
D9 to glycine will likely remove the aspartate ability to coordinate divalent ion,
hence creating an unphosphorylatable CpdR. This may confer a general
activation towards active binding for CpdR mutants, particularly if normal CpdR
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Figure 4-6 Co-location of CpdR residue D9 in CheY structure
(A)! Ribbon diagram of CheY (light purple) overlaid with CpdR (light pink) using PyMol.
Stick representation of the phosphorylation site: CheY D57(light blue), CpdR
D51(pink). Circled stick representation of aspartate residues that coordinate Mg2+,
CheY D12 and D13 (blue), and potentially CpdR D9 (red).
(B)! General depiction of single-domain response regulator (SD-RR) protein (adapted
from (Bourret, 2010a)) and CpdR shown in the schematic. In SD-RR, several
aspartate residues (including the aspartate for phosphorylation) coordinate
magnesium. For CheY, D12 and D13 coordinates magnesium together with D57.
D12 in CheY forms salt bridge with K109, a lysine residue in 5 5 loop, when
bound by Mg2+. H104 residue in CpdR could be in the same 5 5 loop as that
lysine residue (identified as K101 in CpdR).
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Figure 4-7 D9G mutation prevents phosphorylation
(A)! D9G is introduced into BACTH T25-CpdR wildtype, R106A and H104A variant
plasmids. BACTH interactions with T18-C. crescentus T18-ClpX were examined.
Data from Ying Zhi Zhang.
(B)! (i) In vitro phosphorelay profiling of CpdR wildtype (WT)32and D9G D11E K97R
H104A, D9G, and D51A variants using radiolabeled ATP ( P). 10 and 40 minutes
after exposure of CpdR to the phosphosignaling cascade CckA and ChpT with
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radiolabeled ATP at 30 °C, samples were collected for examination by SDS-PAGE
followed by phosphoimaging.
(ii) Phosphorylated CpdR were examined for ability to mediate GFP-PdeA
degradation by ClpXP. CpdR wildtype and D51A and D9G variants were
preincubated for 40 minutes at 30 °C prior to addition to the degradation mixture.
A split version of CckA in which the histidine kinase (CckA-HK) and receiver
domains (CckA-RD) are separate polypeptides were used to minimize
dephosphorylation (Chen et al., 2009). ChpT is a phosphotransferase that mediates
phosphotransfer from CckA to CpdR (Biondi et al., 2006b).
(C)!BACTH assays was performed to compare the interactions of C. crescentus ClpX
(T18-ClpX) with CpdR wildtype, CpdR D51A (site of phosphorylation mutated to
alanine) and CpdR D9G. clpX variant of the reporter E. coli cya was also used
to avoid effects that could be introduced due to degradation of T25-CpdR by E. coli
ClpX.

can be phosphorylated promiscuously in the E. coli BACTH reporter strain thus
reducing the ability of CpdR to bind to its partner protein.

To test this hypothesis, we introduced D9G into CpdR wildtype, and its variants
R106A and H104A. If this hypothesis is true, we expect a general activation of
CpdR binding to its partner ClpX. The D9G mutation resulted in significant
improvement in ClpX interactions with CpdR wildtype, and both the variants
R106A and H104A (Figure 4-7A). We are not sure why, but interaction with T18PdeA was variable between independent colonies (data not shown); these
results need to be retested.

Next, we determined whether the quadruple mutant and CpdRD9G variant
proteins truly cannot be phosphorylated. Using wildtype CpdR as a positive
control and CpdRD51A (phosphorylation site is mutated to alanine) as a negative
control, we checked for phosphorylation using radiolabeled ATP, and found that
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the quadruple mutant and CpdRD9G cannot be phosphorylated (Figure 4-7B(i)).
CpdRD9G is also resistant to phosphorylation as shown by its ability to mediate
degradation of GFP-PdeA by ClpXP even after preincubation with its cognate
phosphosignaling cascade (Figure 4-7B(ii)).

CpdRD51A and CpdR D9G is clearly not phosphorylatable, but we note that
activity of CpdR wildtype, CpdRD51A and CpdRD9G appeared to be in this order
CpdR wildtype< CpdRD51A<CpdRD9G in Figure 4-7B(ii). From our experience,
concentration measurements of CpdR variants need to be verified by SDS-PAGE
gel, and protein activity can vary between different batches, so it is important to
verify differences between CpdR variants using proteins purified from the same
batch. Proteins used in Figure 4-7B(ii) were from different batches (Ying Zhi
Zhang prepared CpdR D9G and CpdR wildtype and Joanne Lau prepared
CpdRD51A). We attempted to verify the differences in the in vitro activity
between unphosphorylated CpdR wildtype, CpdRD51A, and CpdRD9G later
(Figure 4-8A(i)).

If resistance to phosphorylation due to the D9G mutation is the only reason that
causes increase of the interactions with ClpX in BACTH studies, we expect that a
mutation at CpdR phosphorylation site (CpdR D51A) that retains activity similar
to unphosphorylated wildtype CpdR should provide the same effect in the
BATCH studies. Qualitatively, CpdR D51A did indeed show higher interactions
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with ClpX when compared to wildtype CpdR (Figure 4-7C). (As an aside, this
result also indicates that promiscuous phosphorylation of CpdR could occur in
the BACTH E. coli reporter strains.) Interestingly, interaction with ClpX is better
with the D9G variant than the D51A variant, as observed from the deeper red
coloration in the McConkey agar (Figure 4-7C).

We next determined whether the improvement in interaction with ClpX due to
D9G (Figure 4-7C) translates to improvement in adaptor activities. The variants
of CpdR: CpdR D9G, CpdR D51A, and CpdR D9G D51A were examined for
ability to mediate GFP-PdeA degradation by ClpXP (Figure 4-8A(i)). We also
generated a similar set of variants that are non-degradable (CpdRDD) to avoid
competition from CpdR degradation with degradation of its adaptor-dependent
substrate PdeA (Figure 4-8A(ii)). CpdR D9G and its non-degradable variant
attained a lower Kactivation compared to wildtype and CpdR D51A (Figure 4-8B).
The double mutant D51A D9G and its non-degradable variant showed worse
adaptor activity than wildtype CpdR, verifiable by measurements of Kactivation
and Vmax (Figure 4-8A,B).

It appears from in vitro data that the D9G mutant activates CpdR beyond what
we normally see for CpdR activity. We decided to test whether the effect could be
seen in C. crescentus. The effect of CpdR in C. crescentus is pleiotropic because
multiple substrates are influenced by its activity, and it may not be feasible to
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isolate specific biological effects because of this complexity. However, it is known
that the non-phosphorylatable CpdR D51A negates swarming phenotype in soft
agar (Figure 4-4B), so we used this phenomenon to test the effects of D9G. We
saw similar reduction in colony size as D51A for D9G and the double mutant
D9G D51A (Figure 4-8C). The similar effects confirm that D9G is a nonphosphorylatable variant of CpdR (Figure 4-7B).

We could not distinguish between the effects of the D9G/D51A variants when we
introduced the mutations in CpdR, so we decided to test these same mutations in
a R106ADD background. R106A mutation weakens CpdR interaction with ClpX
(Figure 4-4D,E) and we had previously observed that the D51A R106A variant of
CpdR does not cause as huge a reduction in swarming phenotype as compared
to the D51A variant (Figure 4-4B). This may give rise to a larger dynamic range
to detect activating effects for the D9G CpdR variant that was observed in vitro
(Figure 4-8A,B), if any exist. Replacement of the natural C-terminal di-alanine of
CpdR with diaspartate (DD) prevents variability in levels of the expressed
proteins due to degradation by ClpXP.

Using the R106ADD background, we found that the CpdR D9G variant was
slightly more potent in reducing soft agar swarming phenotype than the D51A
variant (Figure 4-8C). The D9G D51A double mutant did not appear to be as
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effective as D9G alone (Figure 4-8D), reminiscent of the non-additive effects of
these two mutations observed in vitro (Figure 4-8A,B).

In summary, when compared to the non-phosphorylatable D51A CpdR variant,
the D9G CpdR variant shows stronger binding to ClpX (Figure 4-7C), improves
CpdR ability to deliver substrate PdeA to ClpXP (Figure 4-8A,B), and can be
more potent in C. crescentus (Figure 4-8D). Taken together, these results
indicate that CpdR D9G is an activated form of CpdR. The fact that CpdR D9G
cannot be phosphorylated and is co-located with the D12 and D13 in CheY
strongly hints that CpdR D9 is normally important to coordinate Mg2+ for
phosphorylation events.
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Figure 4-8 D9G activates adaptor function in CpdR
(A)! Adaptor activity in vitro was assayed for CpdR wildtype, CpdR D51A, D9G, and a
double mutant D9G D51A. Initial rates of degradation of GFP-PdeA by ClpXP were
measured as a function of increasing adaptor concentrations. Kinetics of the (i)
degradable and (ii) non-degradable variants of these adaptors are reported
(Kactivation and Vmax) (iii).
(B)! The effect of D9G mutation examined in C. crescentus by soft agar assay. CpdR
variants (D51A, D9G, and D9G D51A) in a R106ADD background were expressed
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using xylose-inducible plasmids. The strains were examined by colony stabbing on
soft agar (PYE 0.3% agar, spectinomycin antibiotics, and 0.2% xylose as inducer).
Representative images of colonies are shown, and colony area (mean SD, n=6)
normalized to the strain carrying the empty plasmid (no CpdR) is shown.

4.5 Discussion
4.5.1 Mechanistic lessons learned from regulating the protease-priming
mechanism
Our data shows that phosphorylation is key to modulating CpdR binding to ClpX
(section 4.2). We also see that this modulation is specific to the N-terminal
domain of ClpX. On hindsight, regulating the binding of CpdR to ClpX makes
sense. If phosphorylation were to gate the formation of a recruitment platform,
this could mean that CpdR may occupy ClpX N-terminal domain even when it is
inactivated by phosphorylation. This could prevent ClpX from performing its other
tasks, such as those associated with other NTDClpX-dependent adaptors
(eg. SspB (Figure 4-2) or delivery of other substrates that utilize NTDClpX
as an anchorage point to enter the unfoldase.

In the bigger picture, adaptor regulation is key even for scaffolding adaptors to
prevent unnecessary occupancy of their cognate AAA+ protease. Modulation of
only the substrate-binding domain or the protease-binding domain of the scaffold
may cause one or the other domain to unnecessarily occupy the substrate or the
protease, preventing normal function. Constitutive occupation of a substrate by
its adaptor may be justifiable if it were an evolutionarily evolved mechanism to
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modulate the function of the substrate. Similarly, constitutive occupation of the
active AAA+ protease does not make sense, unless it confers necessary
function. This can be seen in the case of the scaffolding adaptor MecA, where its
constitutive occupation of its AAA+ unfoldase partner, ClpC, is sensible because
of its essential function for ClpC oligomeric state and formation of the protease
ClpCP (Kirstein et al., 2006). It appears fitting in this case that the MecA
substrate-binding domain is the target for modulation (through its anti-adaptor,
ComS) (Persuh and Turgay, 1999).

4.5.2 Regulating the protease-binding mechanism also regulates selfdegradation
Regulation of CpdR-binding to ClpX through phosphorylation (Section 4.2) could
explain why CpdR degradation was previously seen to be regulated in a
phosphorylation-dependent manner (Iniesta and Shapiro, 2008). Iniesta and
Shapiro had shown that the turnover rate of CpdR is faster when the
phosphorylation site, D51, is mutated to alanine. CpdR is thought to be
recognized for degradation through its C-terminal di-alanines, which constitutes a
degron for ClpX recognition. Based on our results in Section 4.2, CpdR D51A
binds constitutively to ClpX, therefore this can increase the chances for ClpX to
recognize the C-terminal dialanine tail of CpdR.
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4.5.3 Links between CpdR D9G and its parental output face mutant H104A
H104A mutation in the CpdR α5-β5 loop disrupted interaction with ClpX (Figure
4-3D,E). It is still not certain whether H104 is an actual binding site to ClpX or a
mutation that affects the conformation in other parts of CpdR. It could be that the
compensatory D9G mutations discovered through the suppressor screen were
serendipitous rather than necessarily linked to screen performed by BACTH
using CpdRH104A as the parental protein. However, it is known that CheY D12
residue can form a salt bridge with K109 when CheY is bound to Mg2+ in the
absence and presence of phosphorylation. CheY K109 CheY maps to CpdR
K101, based on the CpdR homology structure (Figure 4-6). What is interesting is
that CpdR K101 is located in the same α5-β5 loop as CpdR H104 (depicted in
the schematic shown in Figure 4-6). If this homology structure for CpdR is
sufficiently accurate, and if conformational modulation due to Mg2+-binding is
universal amongst response regulators, the loop co-location between CheY K109
and CpdR H104 may be an underlying reason why the D9G mutation occurred
so frequently during the BACTH screen.

4.5.4 Dynamic states that may be occupied by CpdR
The mapping of CpdR D9 residue to CheY D12/D13 (Figure 4-6) suggests that
D9 may be a residue that is important to coordinate Mg2+. This could explain why
D9 can affect the phosphorylation of D51 in CpdR. It will be important to examine
the binding affinity of CpdR D9 for Mg2+, as compared to wildtype CpdR to be
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certain of this hypothesis. It will also be very interesting to examine whether
Mg2+-free CpdR can bind more tightly to ClpX, like CpdR D9G. Sensitive in vitro
interaction methods (cell-free, i.e. not BACTH assay) will be necessary for this
assay to be able to control Mg2+ concentrations.

Mg2+-free CheY adopts a very different conformation from Mg2+-bound CheY,
affecting regions in the protein beyond the active site that coordinates Mg2+
(Bellsolell et al., 1994). If this is also occurring in CpdR, it may allow Mg2+-free
CpdR to bind more tightly to ClpX (and this is possibly a state that is represented
by CpdR D9G) (Figure 4-9).

We observed that CpdR D9G has a different size exclusion chromatography
profile than wildtype CpdR during our protein purification steps. Normally, only
approximately one-fifth of wildtype CpdR is kept for experiments because this
comes from an identifiable monomeric state protein, termed “lower molecular
weight species” in Figure 4-10 (arrow). The higher molecular weight proteins
appear to be CpdR proteins on SDS-PAGE gel, but have apparent molecular
weights that range from 44kD to 670kD, and so could be moderately aggregated
proteins. CpdR D9G purification increased the ratio of the lower molecular weight
species to the higher molecular weight species. We have not seen this clearly
occurring with other CpdR variants used during our study. Perhaps CpdR D9G is
less prone to aggregation, and importantly, this could be an indicator of a
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difference in protein conformation from wildtype CpdR. Other biophysical
methods should also be explored to see if conformation changes in Mg2+-free
CpdR and Mg2+-bound CpdR, and CpdR D9G is measurable.

It is curious why the S100F residue suppressed D9G compensatory effects in
CpdR H104A (Figure 4-5B). Testing the effects of S100F D9G in CpdR wildtype
may be useful to see if it abolishes the activating effects of D9G. This could be
further support for D9G ability to affect the overall conformation in CpdR.

If the activity of a Mg2+-free state of CpdR is detectable, such as in the case of
the CpdR D9G variant, this is a unique dynamic state that exist but cannot be
enzymatically assayed in most response regulators. In CheY, for instance,
conformation of the Mg2+-free state can be assessed structurally, but there is no
known activity associated to this state because it may simply be a different
conformation of an inactive protein, and it is not possible to further inactivate an
already inactive protein (Figure 4-9).
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Figure 4-9 Dynamics between the active and inactive states of CheY and
CpdR
Unphosphorylated CheY is inactive in its ability to bind to its partner. Binding to Mg2+ is
necessary for phosphorylation to occur to produce the active form of the protein. Mg2+
binding is dispensable after phosphorylation. The active/inactive state is flipped in CpdR,
in contrast to known single-domain response regulator proteins including CheY. CpdR is
active when unphosphorylated and is inactive when phosphorylated. It is known that
Mg2+ -free CheY contains a different structural conformation than when bound with Mg2+.
Extending that observation to CpdR, it is possible that binding to Mg2+ changes the
conformation of CpdR, and Mg2+-bound CpdR is pre-disposed to phosphorylation. Mg2+free CpdR could be an active form of CpdR that is not pre-disposed to phosphorylation,
and perhaps is represented by the mutant variant, CpdR D9G.
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Figure 4-10 Purification of CpdR D9G gives higher yield of lower molecular
weight protein than wildtype CpdR.
His-SUMO tagged CpdR, cleaved to yield an untagged protein, is normally further
purified by size exclusion chromatography (SEC). Typically, the lower molecular weight
peak fractions (~13kD, CpdR monomer) are kept for in vitro study, and higher molecular
weight species (ranging 50 to 670kD) is discarded. The SEC profile for wildtype CpdR is
consistent through the years (see top right chromatogram from 2011 compared to
wildtype and non-degradable variant of CpdR on the left). Interestingly, CpdR D9G and
its non-degradable variant CpdR D9GDD show a higher ratio of lower molecular weight
species to higher molecular weight species.
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CHAPTER 5
CPDR ADAPTOR MECHANISM EXTENDS TO OTHER CELL CYCLEREGULATED SUBSTRATES
5.1 Introduction – emerging studies indicate more substrates are adaptor
modulated
Although many ClpXP substrates require CpdR for degradation in vivo, at the
time when this study of CpdR adaptor mechanism started, PdeA was the only
substrate shown in vitro to be solely dependent on CpdR and ClpXP (Abel, et al.
2011; Rood, et al. 2012). Our studies with the CpdR output face variants that
affect binding to ClpX indicated that other substrates beyond PdeA could be
affected by the CpdR priming mechanism (Figure 4-4C). In particular, these
CpdR variants affect CtrA degradation in vivo (Figure 5-1A).

Initially it was confusing whether CtrA degradation is solely regulated by the
localization mechanism of CpdR since the degradation of CtrA by ClpXP can be
constituted without the need for any adaptors (Chien et al., 2007b). Eventually,
early work in the Chien Lab began to clarify that CtrA degradation by ClpXP can
be inhibited when bound to its cognate DNA, such as oriC or regulatory regions
for flagellar regulation (fliF promoter) (Gora et al., 2013). Regulated degradation
of the master regulator CtrA, when bound to its cognate DNA, was then shown in
vitro using a multi-protein adaptor complex that includes CpdR, RcdA and PopA
(Smith et al., 2014). Here in this chapter, we show evidence that the CpdR-
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priming mechanism can indeed affect the multi-adaptor-complex responsible for
delivering substrate CtrA to the AAA+ protease ClpXP.

5.2 CtrA degradation depends on the priming mechanism of CpdR
The output face variants of CpdR support similarly timed but less dramatic
oscillations in CtrA levels during cell cycle when present as the sole copy of
CpdR in vivo (Figure 5-1A). These ClpX binding-deficient variants of CpdR are
also deficient in adaptor-dependent degradation of CtrA in vitro (Figure 5-1B).

Like for delivery of PdeA mediated by CpdR, the NTDClpX is necessary for
adaptor-complex dependent degradation (Figure 5-2A). Using the tethered
FKBP-FRB system (Figure 3-6), we could see faint but consistent delivery of
CtrA and GFP-tagged CtrA (Figure 5-2C,D). The effect is specific because
testing the same system for delivery of GFP-ssrA did not result in an activation
that depends on proteins needed to form the multi-adaptor complex (Figure
5-2E). Delivery by GFP-ssrA appeared to be suppressed in manner that is
correlated to the addition of more proteins (Figure 5-2E). Perhaps this artificial
tethering system, which involves two tethering proteins (FKBP, FRB), combined
with the necessary components for adaptor-dependent delivery (CpdR, RcdA,
and PopA and NTDClpX fragment) created sufficient steric hindrance to inhibit
robust degradation of CtrA/GFP-CtrA (Figure 5-2C,D).
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Figure 5-1 Impact of CpdR output face variants on degradation of CtrA by
ClpXP
(A)! R106A and H104A mutations in the output face of CpdR that normally affects
binding to ClpX modulates cell cycle-dependent degradation of CtrA
(B)! Impact of CpdR output face mutation on in vitro degradation of CtrA by ClpXP in the
presence of cognate DNA (FliF promoter) and its multi-adaptor complex RcdA,
PopA, and cyclic-di-GMP (cdG).
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Figure 5-2 ClpX-priming by CpdR modulates CtrA delivery
N-ClpXP in the
(A)! CtrA degradation in vitro to compare degradation ClpXP and
presence of cognate DNA (fliF promoter) and the multi-adaptor complex CpdR,
RcdA, PopA, and cyclic-di-GMP (cdG).
(B)! CtrA degradation in the FKBP/FRB tethering system. Degradation of CtrA bound to
cognate DNA (FliF promoter) by FKBPN-ClpXP (±FRB-CpdR/NTDClpX
fragment/additional adaptors (RcdA, PopA, cdG)) in the presence of rapamycin.
(C)!GFP-CtrA RD+15 degradation in the FKBP/FRB tethering system. Degradation of
GFP-tagged CtrA RD+15 by FKBPN-ClpXP (±FRB-CpdR/NTDClpX
fragment/additional adaptors (RcdA, PopA, cdG)/rapamycin). RD+15 omits the DNAbinding domain of CtrA, and contains the N-terminal receiver domain (RD) of CtrA
critical for the multi-adaptor delivery and the C-terminus 15 residues that are
important for recognition by ClpXP ATPase domain (Smith et al., 2014). Graphs are
represented as mean ± SD, n=3. Tukey post hoc test built on one-way analysis of
variance (ANOVA), performed using GraphPad Prism, indicate that tethered FRBCpdR (i.e. plus rapamycin) in the presence of other adaptors (RcdA, PopA-cdG) and
NTDClpX together result in a slightly higher rate of delivery compared to addition of
only NTDClpX (***p<0.001) or the additional adaptors (RcdA and PopA in the
presence of cdG) (**p<0.01).
(D)!Degradation of GFP-ssrA (1µM) by FKBPN-ClpXP (±FRB-CpdR/NTDClpX
fragment/additional adaptors (RcdA, PopA, cdG)) in the presence of rapamycin.
Graphs are represented as mean ± SD, n=3.
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(A-D) performed in triplicates. Representative gels are shown.

5.3 Discussion
5.3.1 Delivery of many other substrates depends on the priming
mechanism of CpdR
The discovery that CtrA could be delivered through the multi-adaptor complex,
CpdR, RcdA and PopA, showed that PdeA is not the only substrate governed by
the adaptor mechanism. In this chapter, we show that the protease-priming
mechanism discovered based on PdeA extends to CtrA delivery by the multiadaptor complex (Figure 5-2C,D).

This priming mechanism applies to many more substrates. Similar to PdeA,
degradation of the chemoreceptor McpA in vivo is strictly dependent on CpdR
(Iniesta, et al. 2006) and not on other regulators (McGrath et al., 2006; Duerig et
al., 2009). Studies of McpA became a major work of Lisa Hernandez-Alicea in
the Chien Lab. She and Robert Vass (Chien Lab) showed that like PdeA,
degradation of McpA in vitro by ClpXP can be mediated by CpdR (Lau et al.,
2015). Degradation of McpA was affected by mutation of CpdR in the same rank
order as PdeA degradation and a similar dependence on the NTDClpX as with
PdeA (Lau et al., 2015). Together, these results suggest that McpA degradation
is governed by similar mechanisms that we have detailed for PdeA, and reveal a
second member of ClpXP substrates that are directly delivered by CpdR.
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In parallel, major work by Kamal Joshi (Chien Lab) with RcdA revealed that RcdA
and CpdR work together in a tandem mode to recruit multiple proteins (Joshi et
al., 2015). RcdA requires both CpdR and NTDClpX to anchor onto ClpX,
reminiscent of the priming-mechanism shown for delivery of PdeA (Joshi et al.,
2015). His work showed that RcdA recruitment of PopA as an adaptor created a
multi-tiered adaptor system that delivers numerous substrate.

5.3.2 Localization model is perhaps a manifestation of the adaptor system
Based on these studies by multiple members of Chien Lab, it is clear that the
interaction between CpdR and ClpX generates a composite recruitment interface
for binding multiple substrates directly (e.g. PdeA and McpA) in addition to
recruitment

of

additional

adaptors

(e.g.

RcdA)

that

further

expand

substrate specificity (Figure 6-1B). It is curious whether there may be other
adaptors or substrates that can further modulate ClpXP during the Caulobacter
cell cycle. It has been a difficult endeavor to discover these adaptors, relying
mostly on trial and error. However, in hindsight, much of our findings evolved
from early studies of the localization mechanism of ClpXP and the substrates.
These proteins that regulate localization of ClpX (such as CpdR) or the substrate
CtrA (RcdA, PopA) turned out to function as adaptors.
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It is uncertain whether the localization mechanism works hand-in-hand with the
adaptor mechanism. Taylor and colleagues have suggested that localization of
ClpXP substrates could be decoupled from their degradation in vivo (Taylor et al.,
2009). We show that CpdR variants that weaken ClpX binding affect both
localization of ClpX and CpdR-dependent ClpXP activity (Figure 4-4D). This data
could support the original localization model where co-localization promotes
degradation because effects on degradation mirror changes in localization.
Alternatively, CpdR activation at the incipient pole (Tsokos and Laub, 2012)
could be temporarily producing protease-substrate-adaptor foci, a transient
process that is relieved when substrates are degraded or adaptors are
inactivated. This implies that loss of adaptors should result in loss of protease
foci. In support of this alternative model, PopA, a component of the CtrA adaptor
complex (Smith, et al. 2014), also contributes to ClpX foci formation (Duerig et
al., 2009). Therefore, we favor a model where foci attributed to localization of the
protein factors are a manifestation of the adaptor system, rather than driving
degradation itself.
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CHAPTER 6
CONCLUSIONS

Cell cycle-regulated proteolysis in C. crescentus depends on an intricate network
of phosphosignaling proteins that modulates CpdR (Kirkpatrick and Viollier,
2012). Activation of CpdR function relies on its ability to translate cues from an
intricate network of phosphosignaling proteins into a decision to modulate ClpX.
This decision is an important one because CpdR activity regulates a diverse
range of protein factors involved in modulating bacterial cell cycle.

6.1 The protease-priming model for cell cycle-dependent degradation
Although CpdR functions as a ClpXP adaptor, it was unclear before our study,
shown through this thesis, how this molecule couples its phosphorylation status
to a mechanism for delivering multiple substrates. In our study, we show that
phosphorylating CpdR prevents its binding to ClpX. Dephosphorylated CpdR
binds ClpX N-terminal domain to prime, or prepare, a recruitment interface
(Figure 6-1). This interface affords engagement of multiple substrates as well as
additional adaptors that aid substrate delivery (Figure 6-1) (Smith et al., 2014;
Joshi et al., 2015; Lau et al., 2015). We propose that the priming mechanism
causes dynamic assembly of complexes needed for regulated degradation of
many

substrates

with

biological

consequences.

For

example,

the

phosphodiesterase PdeA normally maintains low levels of cyclic-di-GMP levels in
swarmer cells for improved motility (Abel et al., 2011), the chemoreceptor McpA
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helps swarmer cells search for nutrient replete regions in the environment (Alley
et al., 1991), and the transcriptional factor TacA plays an important role in
modulating stalk biogenesis (Joshi et al., 2015). CtrA plays a critical role as an
inhibitor of replication (Quon et al., 1998), and must be maintained to prevent
inappropriate replication initiation while swarmer cells are searching for a suitable
habitat. Degradation controlled by modulating CpdR activity could facilitate cell
reprogramming by removing these specific proteins when cells are ready to enter
its replicative sessile state.

6.2 CpdR adopting multiple conformations?
Our working model is that phosphorylation affects the equilibrium among CpdR
conformations, similar to other response regulators (Bourret, 2010b). In the case
of CpdR, phosphorylation favors an output face configuration that blocks ClpX
binding. We do not know specifically how CpdR primes ClpX; however, as
illustrated in Figure 6-1A(ii), binding of CpdR to the NTDClpX could induce
conformational changes in CpdR, the NTDClpX, or both that promote recruitment
of substrates and additional adaptors. Alternatively, CpdR and ClpX may each
provide weak interactions that collectively result in strong binding of additional
factors (Figure 6-1A(i)). The oligomeric nature of ClpX could also promote
a polyvalent display of CpdR that increases binding to substrates or
downstream adaptors. How CpdR-NTDClpX recruits multiple downstream
components remains an outstanding question.
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In our quest to search for suppressor mutants of a CpdR variant (H104A) that is
defective in binding to ClpX, we found an activated non-phosphorylatable variant
of CpdR (D9). Structural studies from CheY indicate that this mutation may
coordinate Mg2+ to enable phosphorylation events. Mg2+ binding is associated to
protein-wide conformational changes in CheY (Bellsolell et al., 1994). Our
preliminary data supports that the activated D9G mutant has some different
biophysical properties than wildtype CpdR. This CpdR variant may have adopted
a Mg2+-free conformation, giving us insight to the dynamic states that CpdR may
naturally adopt during its regulatory function.

6.3 Advantages of a regulated protease-priming adaptor
Through this work we show how a protease-priming adaptor regulates cell cycledependent proteolysis in Caulobacter. This unexpected mechanism has an
advantage over scaffolding adaptors in that an excess concentration of adaptor
does not inhibit target degradation. Mechanistically, regulating the proteasepriming mechanism through the adaptor ability to bind ClpX is sensible so that
the adaptor occupies ClpX only when needed.

We note that CpdR is critical in the α-proteobacterium Sinorhizobium meliloti for
nitrogen fixation in legumes (Kobayashi et al., 2009) and can function even with
ClpX from E. coli, a γ-proteobacterium. Given the fact that almost all bacteria
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encode ClpX, we speculate that priming adaptors for ClpX will exist in other
species.

Figure 6-1 The priming mechanism by CpdR controls proteolysis during
the Caulobacter cell cycle
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(A)! Model for the protease priming mechanism discovered through work done in this
thesis. During the Caulobacter cell cycle, the adaptor CpdR is kept phosphorylated
in swarmer cells (G1 state) preventing interactions with ClpX. When the swarmer
cell transitions into its stalked cell state (G1-S), dephosphorylation of CpdR
promotes binding to the N-terminal domain of ClpX, priming it to recruit downstream
components. This primed complex can directly recruit degradation substrates such
as PdeA, and recruit additional adaptors (RcdA, PopA-cdG) known to deliver CtrA
for degradation (Smith et al., 2014; Lau et al., 2015). CpdR and NTDClpX could both
be contributing individual weak interactions to promote cargo recruitment (i), or
binding could be inducing conformational changes to promote cargo recruitment (ii).
(B)! The discovery of the protease priming-mechanism has been useful in the work of
Chien Lab members, Kamal Joshi, Lisa Hernandez-Alicea, and Robert Vass who
have extended our understanding of how many more substrates are recruited for
delivery to ClpXP during the cell cycle. The substrate McpA is also recruited through
the protease-priming recruitment surface provided by NTDClpX and CpdR (Lau et al.,
2015). Another adaptor, RcdA functions in tandem with CpdR to recruit TacA and
other substrates (Joshi et al., 2015). PopA functions in tandem with RcdA and CpdR
to recruit CtrA (cyclic-di-GMP modulates the substrate-binding action of PopA)
(Smith et al., 2014; Joshi et al., 2015).

115

CHAPTER 7
FUTURE DIRECTIONS

7.1 Understanding how CpdR-NTDClpX creates a recruitment platform for
multiple downstream factors
The CpdR-priming mechanism provides a platform that directly modulates the
substrates PdeA and McpA and cooperatively modulates a different range of
substrates through the adaptors RcdA and PopA that bind in tandem to CpdR.
How CpdR creates that recruitment platform is a good question and mystery that
is yet to be solved. CpdR potentially adopts a range of conformations, such as
those when CpdR is phosphorylated, unphosphorylated, and ClpX-bound.
Detecting these conformation can allow us to better visualize what is happening
at each step.

7.1.1 Co-crystallography approach
Earlier, protein crystallography using wildtype CpdR protein yielded precipitates
rather than crystals. Now that we better understand the adaptor mechanism of
CpdR, it may be useful to co-crystalize a CpdR-NTDClpX complex, a strategy that
could stabilize CpdR for formation of crystals. Furthermore, the CpdR D9G
mutant discovered through a suppressor screen (Section 4.4) provided at
least 50% higher protein yield of lower molecular weight species in the size
exclusion chromatography step during protein purification (Figure 4-10).
The lower molecular weight species match the 12.7kD protein size of CpdR,
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and the large molecular weight species (possibly aggregated CpdR)
4-10)

appeared much reduced when purifying CpdR D9G.

(Figure

Perhaps the

conformation of CpdR D9G makes it more stable and could be better crystalized.

7.1.2 Nuclear magnetic resonance (NMR) approach
We also previously attempted to perform nuclear magnetic resonance
experiments on CpdR. Two-dimensional NMR studies by N15 labeling was
attempted with the expertise of Dr Anastasia Zhuravleva from Gierash Lab,
UMASS Amherst. The lower molecular weight species CpdR in NMR
experiments was concentrated to 122.6µM. However, Dr Zhuravleva observed
miliseconds exchange between different species. Spectra in the center that
appeared splattered is indicative of aggregation. We assayed the remaining
proteins after NMR experiments using size exclusion chromatography, and found
that the lower molecular weight proteins had indeed shifted to higher molecular
weights. Dr Zhuravleva advised that: 1) adding salts which may help bring down
the aggregation, 2) lowering the temperature during NMR studies (the hardware
problems at that time required that the NMR be performed at 28 °C for two hours
40 minutes, and and 39 °C for 1 h 20 minutes) or 3) improving the stability of the
protein by changing the pH or salts in the buffer (eg. 50mM KCl and 10mM
MgCl2). The CpdR D9G mutant could also potentially be a better behaved CpdR
variant for NMR studies.
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7.1.3 Hydrogen-deuterium exchange mass spectrometry to study
conformation and dynamics of CpdR
We have also tested an automated hydrogen-deuterium exchange mass
spectrometry that is newly available in the Life Science Laboratories with the
hopes of studying the conformation and dynamics of CpdR in different states.
Our initial goal with this new technology had been to assay whether CpdR-ClpX
mixture is different from apo-CpdR and apo-ClpX. In those trials, CpdR and ClpX
were exposed to deuterium for different lengths of times. Hydrogen-deuterium
exchange rates should differ depending on whether the proteins are shielded
from exchange or not. The surface where protein-protein interaction occurs, for
example, could be less exchanged. The proteins that have been exposed to
deuterium is then cleaved using pepsin into small peptides that are identifiable by
weight through mass spectrometry. Incorporation of deuterium that occurs
causes a mass change in the peptide. Unfortunately, we encountered a number
of problems, some of it related to the purity of ClpX, so there was a huge loss of
data where CpdR and ClpX is mixed. It is difficult to purify ClpX to higher purifity,
but we were advised by Dr Steve Eyles (Director, University Mass Spectrometry
Center) that an improved understanding of the separation method which provides
an additional step after liquid chromatography separation of the peptides, should
circumvent this problem.
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7.1.4 Screen for locked conformations
Another approach is to conduct a screen to capture mutants that could be locked
in a specific conformation of CpdR states. The CpdR D9G mutant is a good
example of a mutant that may have been locked into a Mg2+-free state.

A useful mutant would be one that where CpdR may be locked into a substratebinding mode even in the absence of ClpX. If such a mutant is not a simple
artifact, the mutant can answer several questions: 1) Is CpdR the main player to
bind to its downstream components such as PdeA, McpA or RcdA, 2) Does
CpdR undergo conformational shift to achieve that state that binds its
downstream components, 3) Does the mutant bind just one or two or all three of
the known downstream components.

A way to identify this mutation is through BACTH assays. The T25-CpdR and
T18-PdeA interaction is not detectable if E. coli ClpX is removed from the
BTH101 E. coli reporter strain. Similar to the error-prone approach taken in the
suppressor mutant studies of CpdR H104A (Section 4.4), random mutagenesis
of CpdR could yield mutants that can better bind to PdeA. We validate that
the BACTH interaction ClpX-dependent interaction between T25-CpdR and
T18-PdeA is not limited to PdeA. BACTH two-hybrid interactions between
RcdA and CpdR had been previously been shown (Duerig et al., 2009). Like
T25-CpdR T18-PdeA interaction (Figure 2-7), T25-CpdR T18-RcdA interaction
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is abolished in the absence of endogenous E. coli ClpX (data not shown
here). This means that the reliance on E. coli ClpX to attain an interaction
between CpdR and PdeA is not likely to be an artifact or one-time occurence.

The BACTH assay provides the opportunity to screen for mutations in T25-CpdR
that may allow it to remain in a conformation that binds to its known downstream
components (if this conformation exists in nature). Learning about this next step
in the mechanism is useful to establish whether CpdR could perhaps have a
regulated scaffolding mode of action that contains a substrate-binding domain
only when it is activated by the N-terminal domain of ClpX. This study could also
help establish whether CpdR ability to bind such diverse downstream
components occurs through CpdR alone or in conjunction with ClpX (Figure
3-9B), and what contact points are required for different downstream
components.

7.2 CpdR ortholog in other bacteria, eg. E. coli
Promiscuous phosphorylation of CpdR in E. coli cell (Figure 4-7C) may be an
indicator that E. coli has a response regulator pathway similar to those regulating
CpdR phosphorylation in C. crescentus. We have created pBAD-CpdR variant
plasmids (CpdR D51A, CpdR D51ADD and CpdR) to examine whether they may
affect E. coli phenotype. We could test whether a known substrate of CpdR,
PdeA can be degraded in E. coli. A substrate that is normally dependent on C.
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crescentus CpdR could be used in follow-up studies where screening could be
performed using the KEIO knockout collection for E. coli.

7.3 Searching for new adaptors through localization screens

We had discussed in Section 5.3 whether the localization mechanism works
hand-in-hand with the adaptor mechanism, or alternatively, the foci formations
seen in localization experiments visualized through fluorescent protein tagging is
a result of a large number of substrates that need to access the protease
through multiple adaptors in tandem. If the latter is true, it may be feasible to
discover new adaptors for ClpX or any other proteases by identifying gene
deletions that disrupt the localization of fluorescent-tagged protease or
substrate. We could learn from CpdR, RcdA and PopA as a case study where
apparent foci formation of ClpX or substrate may be an indicator of adaptors at
play with their partners. Protease-priming adaptors (like CpdR) appear to
disrupt protease localization, while scaffolding adaptors (like RcdA and PopA)
can disrupt localization of both protease and substrate. It may be too early to
consider conducting a large-scale screen to search for new adaptors, however,
who truly knows if could work until we test it out.
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APPENDIX 1
MATERIALS AND METHODS
Bacterial strains
E. coli Top 10 strain was used for cloning. BL21 DE3 strain was used for
expression of recombinant protein under the control of isopropyl-beta-Dthiogalactopyranoside (IPTG)-inducible T7 promoter.
BACTH E. coli cya clpX strain (EPC452, F , cya-99, araD139, galE15, galK16,
rpsL1 (Str

r

), hsdR2, mcrA1, mcrB1, ΔclpX) was constructed by P1

bacteriophage (gift from Professor Steven Sandler; UMass Amherst) transduction
of a FRT-flanked ΔclpX::kan marker into the BACTH reporter strain BTH101
(Euromedex). After selection on LB plate containing 50µg/mL kanamycin,
transduction of the ClpX knock-in genotype was verified by Western blot using
affinity purified E. coli ClpX antibody. To remove the kanamycin marker, the clpX
knock-in strain was transformed with pCP20 which expresses flippase to promote
recombination between FRT sites flanking the kanamycin cassette. Removal of
the kanamycin cassette allows for pKT25 (kanR) to be utilized in BACTH
interaction studies.

Plasmid constructions

BACTH plasmids
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CpdR, PdeA and ClpX are cloned in frame into the XbaI and EcoRI site of the
multiple cloning site of pKT25 or pUT18C downstream of the T25 and T18 gene
fragment. Untagged ClpX, ClpX R367K, ClpX E184Q, and NTDClpX (residues 161) sequences were cloned into pCL1920 by Gibson assembly (Gibson et al.,
2009) (pCL1920 Lac promoter DNA sequence (upper case) transitions into the
ClpX

N-terminus

(lower

case)

as

shown:

TCACACAGGAAACAGCTatgacgaaagccgcgagcggcga). pCL1920 backbone was
prepared by PCR for the Gibson reaction.

Plasmids expressed for in vitro protein purification
ClpXA is composed of ClpX residues 1-61 and ClpA residues 145-767. ClpX
residues 1-61 fragment was obtained by PCR using pET23-ClpX (C. crescentus
ortholog) as template. pET23 containing ClpA residues 145-767 was obtained by
PCR using pET23-ClpA C-terminal Δ9 as template. These fragments were
combined by Gibson assembly to create the plasmid for expressing untagged
ClpXA in BL21 strain. The nine C-terminal residues of ClpA (residues 768-776)
are omitted because it acts as an intrinsic auto-degradation tag in vitro as
previously reported for its E. coli ortholog (Maglica et al., 2008). Removal of ClpA
N-terminus (1-144) was determined through alignment between C. crescentus
ClpA and E. coli ClpA, given previous domain studies of E. coli ClpA and
sequence alignment reported in that work showing the conservation of the Ndomain region between divergent organisms (Cranz-Mileva et al., 2008).
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FKBP-ΔN-ClpX is constructed similar to a previous study (Davis et al., 2009),
and consists of the following sequence from N to C-terminus: N-terminal human
FKBP12 protein (108 residues), residues 139–165 of E. coli SspB, a His6 tag,
residues SSHM, residues 59–420 of C. crescentus ClpX. PCR of the “FKBP12SspB(139-165)-His6-SSHM” fragment was done using pACYC-FKBP-ΔN-ClpX
(E. coli ortholog) (Davis et al., 2009) as template. Backbone fragment containing
ΔN-ClpX (C. crescentus ortholog) was amplified using pET23-ΔN-ClpX (C.
crescentus ortholog). The two PCR fragments were combined by Gibson
assembly to produce pET23- FKBP-ΔN-ClpX (C. crescentus).

SspB-FRB consists of the following sequence from N to C-terminus: C.
crescentus SspB residues 10-125 that contains the ssrA binding domain (Chien
et al., 2007b), (GGSG)2 linker, and FRB. CpdR was N-terminally tagged with
FRB with the (GGSG)2 linker in between to allow for flexibility of the construct.
Notably, FRB-CpdR was rapidly degraded by FKBP-ΔN-ClpX•ClpP in the
presence of rapamycin. Replacing the CpdR C-terminal intrinsic degradation tag
(FRB-CpdRDD) did not block degradation, but addition of MD6 residues to the Nterminus of FRB-CpdRDD did, suggesting that the exposed FRB N-terminus is
recognized for degradation by FKBP-ΔN-ClpX•ClpP/rapamycin. The FRB-CpdR
reported throughout this paper refers to this MD6-FRB-CpdRDD construct.
Similarly, FRB-PdeA was constructed to contain an N-terminal MD6-FRB so as to
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prevent N-terminal recognition by FKBP-ΔN-ClpX•ClpP/rapamycin. MD6-FRBPdeADD was constructed with replacement of the PdeA C-terminal intrinsic
degradation tag. All these FRB fusion constructs were cloned into pET23-HisSUMO backbone by Gibson assembly.

CpdR variants (point mutations or C-terminus DD mutation) were generated by
site-directed mutagenesis performed on pET23 His6-SUMO-CpdR for protein
expression.

NTDClpX fragment consisting of residues 1-61 of C. crescentus ClpX was cloned
into pET28-His-thrombin backbone.

GFP-ssrA-SS, where the C-terminus Ala-Ala residue is mutated to Ser-Ser, was
cloned into ML375 for expression of His-thrombin-GFP-ssrA-SS.

The cytosolic portion of McpA (residues 251-657) was amplified from
Caulobacter genomic DNA, and cloned into pET23 His6-SUMO with mGFPmut3 on
the N-terminus of the cytosolic McpA by restriction digestion-ligation. Similarly,
the isolated cytosolic portion of McpA was also cloned into pET23 His6-SUMO
expression vector for production of the untagged version of McpA.

Plasmids for in vivo protein expression in C. crescentus
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Site-directed mutagenesis was performed on pENTR-CpdR or pENTR-CpdR
D51A. The pENTR-variants were then subcloned using the Gateway System
(Invitrogen) into pHX-M2-DEST, pRX2-M2-DEST plasmids (Skerker, et. al. 2005;
Thanbichler, et. al. 2007) or JS14-M2-DEST. These plasmids enable expression
of M2-epitope tagged CpdR WT/variants.

M2-PdeA and M2-GFP-ssrA-SS were cloned into pVGFPC-2 (Thanbichler et al.,
2007) at the NdeI and NheI sites. pVGFPC-2 is an integrating plasmid that
chromosomally integrates into the vanA locus in C. crescentus to generate
vanillate controllable induction.

Error-prone PCR
PCR was performed using standard Taq polymerase (New England Biolabs), 1x
standard Taq reaction buffer (10mM Tris-HCl, 50mM KCl, 1.5mM MgCl2, pH8.3)
20 fmol template was used per 50µL reaction. Additional 7mM MgCl2 and 0.3mM
MnCl2 was added to the reaction to create error-prone PCR conditions. The
program was set up at 95°C 3 minutes denaturation, a 30 cycle of 95 °C 15
seconds, 54°C 15s, 68°C 24s, and elongation of 68°C 10 min. Primers used to
PCR CpdR contained restriction sites XbaI and EcoRI for ligation into pKT25.
Ligation mix buffer was removed by ethanol precipitation prior to cell
transformation.
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Electrocompetant BTH101 E. coli reporter strains that contained either T18-PdeA
or T18-ClpX were prepared for the transformation. Cells were plated sparsely in
a large number of MacConkey agar plates that contain 1% maltose, 0.5mM
IPTG, 50µg/mL kanamycin, and 100µg/mL ampicillin. Colonies that are redder in
coloration than a control plate containing T25-CpdRH104A with T18-PdeA or
T18-ClpX were picked for plasmid harvesting and DNA sequencing.

In vitro degradation assay and phosphotransfer reaction
Degradation assays and phosphotransfer reactions using recombinant protein
components were performed in H-Buffer (20mM HEPES, pH 7.5, 100mM KCl,
10mM MgCl2, 10% glycerol, 5mM β-mercaptoethanol) at 30°C. ClpA activity is
traditionally assayed in buffer containing NaCl; buffer used for ClpA and ClpXA
degradation contained 40mM HEPES, pH 7.5, 220mM NaCl, 27mM KCl, 17mM
MgCl2, 10% glycerol, and 5mM β-mercaptoethanol. Gel-based reactions were
sampled at indicated times, quenched with SDS loading dye, and frozen
immediately. Samples were heated at 95°C for 5 min prior to SDS-PAGE and
Coomassie blue staining, Silver staining, or Western blotting. GFP-tagged
substrates were detected using a 384-well black plate using a Spectramax M5
(Molecular Devices) microplate reader at excitation wavelength 460nm, and
collection of emission wavelength at 540nm with a cutoff of 515 nm. Initial rates
of degradation (Figures 3D & 4F) were fit to an activation model where binding of
CpdR to ClpX activates degradation: v = Vmax*[CpdR] / (Kactivation+[CpdR]) and in
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Figure 3D using (v = Vmax*[NTD] / (Kactivation+[NTD])), performed using GraphPad
Prism version 6 for Mac.

Analytical size exclusion chromatography (SEC) assay
Recombinant proteins were purified to more than 95% homogeneity as described
in Supplementary Experimental Procedures. To assay for interactions in vitro,
50µL mixtures containing recombinant proteins were incubated for 20 minutes at
25°C in H-Buffer prior to injection onto a Superdex 200 5/150 GL size exclusion
chromatography column (GE Healthcare Bio-Sciences, 3mL bed volume)
equilibrated with H-Buffer. CpdR phosphorylation reaction mixtures for SEC
studies were validated by checking for inhibition of adaptor activity when
degrading GFP-PdeA via ClpXP. The rest of the mixture components were
added to the phosphorelay-CpdR mix prior to the SEC injection. SEC
fractionation profiles (50µL per fraction) were examined by SDS-PAGE, followed
by Coomassie blue staining, silver staining, or Western blotting.

Bacterial adenylate cyclase two-hybrid (BACTH) assay
Protein-protein interactions assayed by BACTH (Karimova et al., 1998) were
performed using pKT25 and pUT18C (Euromedex) in the E. coli cya reporter
strain BTH101 (Euromedex). An E. coli cya clpX strain was generated from
BTH101. Interaction between two proteins of interest results in cAMP production,
triggering the expression of several resident genes that allows catabolism of
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maltose or lactose. BACTH plasmid transformants were examined using two
methods: (i) Evaluation of McConkey agar media containing maltose.
Resuspended colonies were streaked on McConkey agar containing 1% maltose,
0.5mM IPTG, 50µg/mL kanamycin, 100µg/mL ampicillin. For Figure 4H, cells
were grown to exponential phase before deposition as 2µL droplets of cells
(diluted equally to OD600=0.3) on the McConkey agar. (ii) β-galactosidase
activity. Cells from the McConkey plates were resuspended in Z-buffer (60mM
Na2HPO4.7H2O, 40mM NaH2PO4.H2O, 10mM KCl, 1mM MgSO4.7H2O, 50mM βmercaptoethanol) before lysis using 0.01% SDS and chloroform (100µL into
500µL samples), and measurement of the supernatant for β-galactosidase
activity (Griffith and Wolf, 2002). We report the rates of formation of the yellow
chromophore o-nitrophenol (ONP) as the hydrolytic product of the action of βgalactosidase on a colorless lactose analog, o-nitrophenyl-D-galactoside
(ONPG), as assayed using a 96-well clear plate using a Spectramax M5
(Molecular Devices) microplate reader. Measurements of ONP were conducted
at 30°C using OD420nm, and the rate of formation was normalized by the cell
density (measured using OD600nm before lysis of the cells).

C. crescentus soft agar plate assay
Colonies of cells that were transformed with plasmids expressing epitope tagged
CpdR (WT or variants) from xylose-driven promoters were inoculate into PYE
media containing 0.3% agar with 0.2% xylose with the appropriate antibiotic
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(5µg/mL kanamycin or 50µg/mL spectinomycin). After incubation at 30°C, colony
sizes were determined using the threshold feature in ImageJ (NIH).

Fluorescence microscopy
Exponential-phased cells were immobilized on 1% (wt/vol) agarose pads made
with PYE + 0.2% xylose. Microscopy was carried out using an epifluorescent
Nikon E600 microscope. An ORCA-ER-cooled charge-coupled device (CCD)
camera (Hamamatsu) and Openlabs software (Improvision) were used for all
image acquisition. A phase-contrast image and z-stack of GFP fluorescence
images (10 steps) was acquired with z-step of 0.3 µm around the focal plane of
the cell. The z-stack images were deconvolved using Volocity 4.0 (Improvision,
Inc.) software. Phase contrast images of C. crescentus cells were outlined
using MicrobeTracker. Stalked pole fluorescence foci were first detected using
the

SpotFinderZ

tool

in

MicrobeTracker,

and

then

verified

visually.

Measurements of the foci intensity from SpotFinderZ were extracted and plotted
in histograms.

Adaptor overexpression studies in vivo
For experiments shown in Figure 3-8 and Appendix 4G and I, strains from PYE
agar plates (2µg/mL chloramphenicol, 0.2% glucose (to suppress JS14
expression)) were inoculated into PYE media (1µg/mL chloramphenicol and 0.2%
glucose) for overnight growth at 30°C in a shaking incubator. Cells sufficient for a
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final resuspension of cell density OD600=0.2 were pelleted. The supernatant
media was removed, and the cells were resuspended into PYE containing
1µg/mL chloramphenicol, 1mM vanillate pH7.5, and 0.2% xylose or glucose, and
grown for 4 hours at 30°C in a shaking incubator. Cells were at exponential
phase (OD600<1) at harvest. Equivalent cell density amounts were sampled for
Western analysis.

Synchrony for in vivo stability assay
For synchronized growth in Figure 5-1A, C. crescentus cells expressing CpdR
variants were grown overnight in PYE media (100µg/mL spectinomycin, 0.2%
xylose) and back-diluted into fresh PYE media (100µg/mL spectinomycin, 0.2%
xylose) at OD600 0.05 for growth to an OD600 of 0.3–0.5. Swarmer cells were
isolated by Percoll density centrifugation, and cells were released into the same
media. Samples were taken at specified time points for Western blot analysis
using antibodies against CtrA and ClpP.

Protein purification by affinity chromatography

Recombinant proteins were overexpressed from IPTG-inducible pET plasmids
and purified as previously reported (Rood, et al, 2012; Bhat, et al. 2013). CpdR,
PdeA, McpA (and their variants) were expressed as C-terminal fusions to a histagged SUMO domain in BL21DE3 plysS cells. Purification of the fusions,
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cleavage of the SUMO domain, and separation of the cleaved protein were
performed as before (Wang et al., 2007). CpdR and variants were further purified
by size exclusion chromatography. SspB (and variants), CtrA (and GFP-CtrA
RD+15), RcdA, and PopA are his-tagged proteins that were purified via standard
Ni-NTA protocols (Qiagen). CckA-HK, CckA-RD, ChpT, GFP-PdeA are also histagged proteins that were purified via standard Ni-NTA protocols, followed by
size exclusion chromatography. ClpX, ΔN-ClpX, ClpA, ClpXA, FKBP-ΔN-ClpX,
and NTDClpX were purified first by Ni-NTA protocol and thrombin cleaved if histagged,

followed

(phenylsepharose,

additional
hydroxyapatite,

column
MonoQ

chromatography
column

or

size

purifications
exclusion

chromatography) (Levchenko et al., 2000; Chien et al., 2007b). Detailed
protocols are available upon request.

Western blotting

Antibodies against CtrA (MA588), PdeA (MA590), ClpX (MA584), ClpP (MA586),
CpdR (HM6663), Flag-M2 (Sigma F1804) and GFP (Clontech JL-8) were used in
this study. Secondary antibodies used were goat anti-rabbit IGG HRP (Millipore
AP187P), goat anti-rabbit IRDye 800CW (Licor 926-32210), and goat anti-mouse
IRDye 680LT (Licor 926-68021). Affinity purified α-PdeA was used throughout.
Affinity purified α-ClpX and α-CpdR were used for BACTH plasmid expression
detection.
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Radioactive phosphotransfer profiling

Radiolabeled phosphorylation of CpdR using cognate phosphorelay proteins
(Figure S4A) were performed in H-Buffer, with additional 5mM MgCl2 to ensure
sufficiency for the phosphorylation reaction to occur. A premix of 0.167 µCi/µL of
radiolabeled ATP (γ32P, Perkin Elmer) and 500µM ATP were added to CckA (split
version (Chen et al., 2009)) for an incubation period of 40 minutes at 30°C to
allow for autophosphosphorylation of the histidine kinase. The phosphotransfer
profiling was initiated upon addition of 1.25µM of the phosphotransferase ChpT
and 5µM of CpdR and its variants. Reaction samples at 30°C were taken after 5
minutes, quenched with SDS loading dye, and frozen immediately. Samples
were examined by SDS‐PAGE, followed by phosphorimaging.

CpdR Phyre modeling and sequence alignment

The online protein fold recognition server Phyre 2 (Kelley and Sternberg, 2009)
was used to build a 3D homology model of CpdR. Conserved residues amongst
α-roteobacteria CpdR orthologs were determined as previously, using one
species for each genus (Brilli et al., 2010).

Bacterial strains used in this work
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Strain
TOP10
BL21(DE3)pLysS
BTH101

BPC129
NA1000 (CB15N)

Description
E. coli cloning strain.
E. coli strain for recombinant protein expression strain
E. coli BACTH reporter strain lacking functional cya
(adenylate cyclase gene for expressing cAMP)
E. coli BTH101 with markerless deletion of clpX using
Flp-FRT recombination
E. coli W3110 ΔclpX::kan
Synchronizable strain of C. crescentus

NA1000 ΔpdeA
NA1000 ΔcpdR::tetR

NA1000 with markerless in frame deletion of pdeA
Disruption of the cpdR gene by a TetR cassette (TetR)

BTH101 ΔclpX

NA1000 ΔcpdR::tetR, xylX::PxylX- NA1000 ΔcpdR::tetR ϕCr30 transduced with xyloseinducible clpX-gfp from
clpX-gfp
NA1000 xylX::PxylX-clpX-gfp (Iniesta et al., 2006) (TetR KanR)
NA1000 ΔsspB
NA1000 with markerless deletion of sspB
W3110
E. coli wildtype strain
W3110 ΔclpX
Kanamycin marker was removed from E. coli W3110
ΔclpX::kan by flip-FRT
NA1000 vanA::PvanA-M2-PdeA +
NA1000 with chromosomally integrated vanillateJS14
inducible M2-PdeA, and high copy empty plasmid JS14
(KanR ChlorR)
NA1000 vanA::PvanA-M2-PdeA +
NA1000 with chromosomally integrated vanillateJS14-M2-Pxyl-CpdRH104ADD
inducible M2-PdeA, and high copy plasmid JS14
expressing M2-tagged CpdRH104ADD (KanR ChlorR)
NA1000 vanA::PvanA -M2-PdeA
NA1000 with chromosomally integrated vanillateΔcpdR::tetR +JS14
inducible M2-PdeA ϕCr30 transduced with NA1000
ΔcpdR::tetR, and high copy empty plasmid JS14 (TetR
KanR ChlorR)
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Reference
Invitrogen
Invitrogen
(Karimova et al.,
1998); Euromedex
This study
T. Baker (MIT)
(Evinger and
Agabian, 1977)
(Abel et al., 2011)
(Skerker et al.,
2005)
This study

Lessner, et al. 2007
T. Baker (MIT)
T. Baker (MIT)
This study

This study

This study

NA1000 vanA::PvanA -M2-GFPssrA-SS
NA1000 vanA::PvanA -M2-GFPssrA-SS+ JS14-Pxyl-M2SspB(SBD)
NA1000 vanA::PvanA -M2-GFPssrA-SS ΔsspB +JS14
NA1000 ΔcpdR::tetR + pRX-M2CpdR
NA1000 ΔcpdR::tetR + pRX-M2CpdRR106A
NA1000 ΔcpdR::tetR + pRX-M2CpdRH104A
NA1000 ΔcpdR::tetR + pHX-M2CpdR
NA1000 ΔcpdR::tetR + pHX-M2CpdRR106A
NA1000 ΔcpdR::tetR + pHX-M2CpdRH104A
NA1000 + pHX-M2-CpdRD51A
NA1000 + pHX-M2-CpdRD51A
R106A
NA1000 + pHX-M2-CpdRD51A
H104A
NA1000 ΔpdeA + pHX-M2CpdRD51A
NA1000 ΔpdeA + pHX-M2CpdRD51A R106A
NA1000 ΔpdeA + pHX-M2CpdRD51A H104A
NA1000 ΔcpdR::tetR xylX::PxylXclpX-gfp + pHX-M2-CpdR
NA1000 ΔcpdR::tetR xylX::PxylXclpX-gfp + pHX-M2-CpdRR106A
NA1000 ΔcpdR::tetR xylX::PxylXclpX-gfp + pHX-M2-CpdRH104A
NA1000 + pHX-M2-CpdRD9G
NA1000 + pHX-M2-CpdRD9G
D51A
NA1000 + pHX-M2-CpdRD9G
R106A DD
NA1000 + pHX-M2-CpdRD9G
D51A R106A DD
NA1000 + pHX-M2-CpdR R106A
DD
NA1000 + pHX-M2-CpdR D51A
R106A DD

NA1000 with chromosomally integrated vanillateinducible M2-GFP-ssrA-SS (KanR)
NA1000 with chromosomally integrated vanillateinducible M2-GFP-ssrA-SS, and high copy plasmid JS14
expressing M2-tagged SspB(SBD) (KanR ChlorR)
NA1000 ΔsspB ϕCr30 transduced with NA1000
vanA::PvanA -M2-GFP-ssrA-SS, and high copy empty
plasmid JS14 (TetR KanR ChlorR)
NA1000 ΔcpdR::tetR and low copy plasmid with xyloseinducible expression of M2-CpdR (TetR KanR)
NA1000 ΔcpdR::tetR and low copy plasmid with xyloseinducible expression of M2-CpdRR106A (TetR KanR)
NA1000 ΔcpdR::tetR and low copy plasmid with xyloseinducible expression of M2-CpdRH104A (TetR KanR)
NA1000 ΔcpdR::tetR and medium copy plasmid with
xylose-inducible expression of M2-CpdR (TetR SpecR)
NA1000 ΔcpdR::tetR and medium copy plasmid with
xylose-inducible expression of M2-CpdRR106A (TetR
SpecR)
NA1000 ΔcpdR::tetR and medium copy plasmid with
xylose-inducible expression of M2-CpdRH104A (TetR
SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2-CpdRD51A (SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2-CpdRD51A R106A (SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2-CpdRD51A H104A (SpecR)
NA1000 ΔpdeA and medium copy plasmid with xyloseinducible expression of M2-CpdRD51A (SpecR)
NA1000 ΔpdeA and medium copy plasmid with xyloseinducible expression of M2-CpdRD51A R106A (SpecR)
NA1000 ΔpdeA and medium copy plasmid with xyloseinducible expression of M2-CpdRD51A H104A (SpecR)
NA1000 ΔcpdR::tetR and medium copy plasmid with
xylose-inducible expression of M2-CpdR (TetR KanR
SpecR)
NA1000 ΔcpdR::tetR and medium copy plasmid with
xylose-inducible expression of M2-CpdRR106A (TetR
KanR SpecR)
NA1000 ΔcpdR::tetR and medium copy plasmid with
xylose-inducible expression of M2-CpdRH104A (TetR
KanR SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2- CpdRD9G (SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2- CpdRD9G D51A (SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2- CpdRD9G R106A DD
(SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2- CpdRD9G D51A R106A
DD (SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2- CpdR R106A DD (SpecR)
NA1000 and medium copy plasmid with xyloseinducible expression of M2- CpdR D51A R106A DD
(SpecR)
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This study
This study

This study

This study
This study
This study

This study
This study

This study

This study
This study
This study
This study
This study
This study
This study

This study

This study

This study
This study
This study

This study

This study
This study

Plasmids used in this work
Plasmid name
pET23 His6-SUMO
pET23b
ML375 DEST (375)
pET28b His6-thrombin
pCP20

pET23 His6-SUMO CpdR
pET23 His6SUMO CpdRD51A
pET23 His6SUMO CpdRDD
pET23 His6SUMO CpdRR106A
pET23 His6SUMO CpdRH104A
pET23 His6SUMO
CpdRH104ADD
pET23 His6SUMO MD6-FRBCpdRDD
pET23 His6SUMO PdeA
pET23 His6SUMO PdeA-ssrA
375 His6-GFP PdeA
pET23 His6SUMO MD6-FRBPdeA
pET23 His6SUMO MD6-FRBPdeADD
pET23 C. crescentus ClpX
pET28 His6thrombin C. crescentus
ClpX
pET23 ΔN-ClpX (C. crescentus
ortholog)
pET23 C. crescentus ClpAΔC9
pET23 C. crescentus ClpXA
pET28 His6 C. crescentus NTDClpX
pET23 FKBP-His6- C. crescentus
ClpXΔN
pET14b His6-E. coli ClpX
pQE70 C. crescentus ClpPHis6
pQE70 E. coli ClpPHis6
375 His6GFP- C. crescentus ssrASS
pBAD GFP- C. crescentus ssrA

Description
T7 promoter; for His6SUMO fusion protein expression
(AmpR)
T7 promoter; for protein expression (AmpR)
DEST expression plasmid; T7 promoter; for His6
thrombin fusion protein expression (AmpR)
DEST expression plasmid; T7 promoter; for His6
thrombin fusion protein expression (KanR)
Temperature-sensitive origin of replication, confers
ampicillin resistance, and encodes the flippase (FLP)
recombinase (AmpR)
For purification of full length CpdR (AmpR)
For purification of CpdRD51A (AmpR)
For purification of CpdRDD (AmpR)
For purification of CpdRR106A (AmpR)
For purification of CpdRH104A (AmpR)
For purification of CpdRH104ADD (AmpR)

Reference
(Wang et al., 2007)

For purification of MD6-FRB-tagged CpdRDD (AmpR)

This study

For purification of full length PdeA (AmpR)
For purification of PdeA-ssrA (AmpR)
For purification of N-terminally his-tagged GFP fused to
the N-terminus of PdeA (AmpR)
For purification of MD6-FRB-tagged PdeA (AmpR)

(Abel et al., 2011)
This study
(Rood et al., 2012)

For purification of MD6-FRB-tagged PdeADD (AmpR)

This study

For purification of untagged C. crescentus ClpX (AmpR)
For purification of His-thrombin C. crescentus ClpX
(KanR)
For purification of untagged C. crescentus ΔN-ClpX
(AmpR)
For purification of untagged ClpA without last 9 Cterminal residues to prevent auto-degradation (AmpR)
For purification of untagged NTDClpX (1-61) fused to
ClpA (145-767) [ΔNTDClpA and ΔC-terminal 9 residues]
For purification of untagged NTDClpX (1-61) through
thrombin cleavage (KanR)
For purification of FKBP-linker fused to ClpXΔN
(AmpR)
For purification of His-tagged E. coli ClpX (AmpR)

(Rood et al., 2012)
(Chien et al., 2007b)

Lac inducible plasmid for purification of his-tagged C.
crescentus ClpP (AmpR)
For purification of His-tagged E. coli ClpP (AmpR)
For purification of GFP-ssrA-ss where C-terminal AlaAla are mutated to Ser-Ser (AmpR)
For purification of GFP-ssrA (AmpR)
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Novagen
(Skerker et al.,
2005)
Novagen
(Cherepanov and
Wackernagel, 1995)
(Abel et al., 2011)
(Abel et al., 2011)
This study
This study
This study
This study

This study

(Bhat et al., 2013)
(Williams et al.,
2014)
This study
This study
This study
(Levchenko et al.,
1997)
(Chien et al., 2007b)
(Kim et al., 2000)
This study
(Chien et al., 2007b)

pET28 His6 CC SspB
pET28 His6 C. crescentus SspB Nterminal Δ9
pET28 His6 C. crescentus
SspB(substrate binding domain,
SBD)
pET23 His6SUMO C. crescentus
SspB-FRB
pHis6-MBP-CckA-HK
pTRX-His6CckA-RD
pTRX-His6ChpT
pET23 His6SUMO GFPmut3cytoplasmic McpA
pET23 His6SUMO cytoplasmic
McpA
pET28 His6CtrA
pET28 His6GFP-CtrA RD+15
pET28 His6RcdA
pET28 His6PopA
pKT25

pUT18C

pUT18C- C. crescentus ClpX
pUT18C-PdeA
pKT25-PdeA
pKT25-CpdR
pKT25-CpdRR106A
pKT25-CpdRH104A
pCL1920

pCL1920-C. crescentus ClpX
pCL1920- C. crescentus
ClpXR367K
pCL1920- C. crescentus
ClpXE184Q
pCL1920- C. crescentus NTDClpX
pRX2 M2-DEST

pRX2-M2-CpdR WT
pRX2-M2-CpdRR106A
pRX2-M2CpdRH104A

For purification of the C. crescentus ortholog of the
degradable SspB wildtype (residues 1-162) (KanR)
For purification of the C. crescentus ortholog of the
nondegradable SspB variant (residues 10-162), SspB*
(KanR)
For purification of the C. crescentus ortholog of the
SspB variant (residues 10-125), SspB(SBD) (KanR)

(Chien et al., 2007b)

For purification of SspB(10-125, SBD)-FRB (AmpR)

This study

For purification of His6-MBP-CckA-HK (AmpR)
For purification of His6-TRX-CckA-RD (AmpR)
For purification of His6-TRX-ChpT (AmpR)

(Chen et al., 2009)
(Chen et al., 2009)
(Biondi et al.,
2006b)
This study

For purification of GFPmut3-McpA residues 251-657
(AmpR)
For purification of McpA residues 251-657 (AmpR)
For purification of His6-CtrA (AmpR)
For purification of His6-GFP-CtrA-RD+15 (AmpR)
For purification of His6-RcdA (AmpR)
For purification of His6-PopA (AmpR)
Derivative of pACYC184 that encodes the T25 fragment
of CyaA (amino acids 1–224) driven by wildtype Plac
(KanR)
Derivative of pBluescript II KS, compatible with pKT25,
that encodes the T18 fragment of CyaA (amino acids
225–399) driven by wildtype Plac (AmpR)
E. coli plasmid for expressing T18-ClpX using Plac
(AmpR)
E. coli plasmid for expressing T18-PdeA using Plac
(AmpR)
E. coli plasmid for expressing T25-PdeA using Plac
(KanR)
E. coli plasmid for expressing T25-CpdR using Plac
(KanR)
E. coli plasmid for expressing T25-CpdRR106A using
Plac (KanR)
E. coli plasmid for expressing T25-CpdRH104A using
Plac (KanR)
Low copy expression plasmid for expression in E. coli,
compatible for co-expression with BACTH plasmids,
wildtype Plac (SpecR)
Plasmid for expressing ClpX (C. crescentus ortholog)
using Plac in E. coli (SpecR)
Plasmid for expressing ClpXR367K (C. crescentus
ortholog) using Plac in E. coli (SpecR)
Plasmid for expressing ClpXE184Q (C. crescentus
ortholog) using Plac in E. coli (SpecR)
Plasmid for expressing NTDClpX (C. crescentus ortholog)
using Plac in E. coli (SpecR)
Low copy DEST vector; xylose promoter; for expression
of FLAG-M2 tagged constructs (KanR) in C. crescentus
Plasmid for low copy expression of Flag-M2-tagged
CpdR WT in C. crescentus (KanR)
Plasmid for low copy expression of Flag-M2-tagged
CpdRR106A in C. crescentus (KanR)
Plasmid for low copy expression of Flag-M2-tagged
CpdRH104A in C. crescentus (KanR)
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(Chien et al., 2007b)

(Chien et al., 2007a)

This study
(Chien et al., 2007b)
(Smith et al., 2014)
(Chien et al., 2007b)
(Smith et al., 2014)
(Karimova et al.,
1998); Euromedex
(Karimova et al.,
1998); Euromedex
This study, similar
to (Abel et al., 2011)
This study, similar
to (Abel et al., 2011)
This study, similar
to (Abel et al., 2011)
This study, similar
to (Abel et al., 2011)
This study
This study
(Lerner and Inouye,
1990)
This study
This study
This study
This study
Derived from
(Thanbichler et al.,
2007)
This study
This study
This study

pRX2-M2-GFP
pHX M2-DEST
pHX-CpdR WT
pHX-CpdRR106A
pHX-CpdRH104A
pHX-CpdRD51A
pHX-CpdRD51A R106A
pHX-CpdRD51A H104A
pHX-GFP-AA
pVan-M2-GFP-ssrA-SS

pVan-M2-PdeA

JS14-Pxyl M2-DEST
JS14 (empty plasmid)
JS14- Pxyl M2-SspB(SBD)
JS14- Pxyl M2-CpdRH104ADD
pHX-M2-CpdRD9G
pHX-M2-CpdRD9G D51A
pHX-M2-CpdRD9G R106A DD
pHX-M2-CpdRD9G D51A R106A
DD
pHX-M2-CpdR R106A DD
pHX-M2-CpdR D51A R106A DD
pET23-His6 SUMO CpdR D9G
D11E K97R H104A
pET23-His6 SUMO CpdR D9G
S100F H104A
pET23-His6 SUMO CpdR D11E
K97R H104A
pET23-His6 SUMO CpdR D9G
H104A
pET23-His6 SUMO CpdR D9G
pBAD- His6 SUMO CpdR
pBAD- His6 SUMO CpdR D9G
pBAD- His6 SUMO CpdR D51A
pBAD- His6 SUMO CpdR D9G
D51A
pBAD- His6 SUMO CpdR DD
pBAD- His6 SUMO CpdR D9G
DD

Plasmid for low copy expression of Flag-M2-tagged
GFP in C. crescentus (KanR)
Medium copy DEST vector; xylose promoter; for
expression of FLAG-M2 tagged constructs (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdR WT in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRR106A in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRH104A in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRD51A in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRD51A R106A in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRD51A H104A in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
GFP-AA in C. crescentus (SpecR)
Plasmid for integration of Flag-M2-tagged GFP-ssrA-SS
at the vanillate-modulatable promoter locus in C.
crescentus (KanR)
Plasmid for integration of Flag-M2-tagged PdeA at the
vanillate-modulatable promoter locus in C. crescentus
(KanR)
Medium copy DEST vector; xylose promoter; for
expression of FLAG-M2 tagged constructs (ChlorR)
Empty medium copy plasmid for C. crescentus (ChlorR)
Plasmid for medium copy expression of Flag-M2-tagged
SspB (12-125, SBD) in C. crescentus (ChlorR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRH104ADD in C. crescentus (ChlorR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRD9G in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdR WT in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRD9G D51A in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdRD9G D51A R106A DD in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
CpdR R106A DD in C. crescentus (SpecR)
Plasmid for medium copy expression of Flag-M2-tagged
D51A R106A DD in C. crescentus (SpecR)
For purification of CpdR D9G D11E K97R H104A
(AmpR)
For purification of CpdR D9G S100F H104A (AmpR)

This study

For purification of CpdR D11E K97R H104A (AmpR)

This study

For purification of CpdR D9G H104A (AmpR)

This study

For purification of CpdR D9G (AmpR)
For purification of CpdR (ChlR)
For purification of CpdR D9G (ChlR)
For purification of CpdR D51A (ChlR)
For purification of CpdR D9G D51A (ChlR)

This study
This study
This study
This study
This study

For purification of CpdR DD (ChlR)
For purification of CpdR D9G DD (ChlR)

This study
This study
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(Skerker et al.,
2005)
This study
This study
This study
This study
This study
This study
This study
This study

This study

M. Laub (MIT)
M. Laub (MIT)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study

pBAD- His6 SUMO CpdR D51A
DD
pBAD- His6 SUMO CpdR D9G
D51A DD
pKT25-CpdR D9G D11E K97R
H104A
pKT25-CpdR D9G S100F H104A
pKT25-CpdR D9N S100F H104A
pKT25-CpdR D9N V103M
H104A
pKT25-CpdR D9G
pKT25-CpdR D9G R106A
pKT25-CpdR D9G H104A
pKT25-CpdR D51A

For purification of CpdR D51A DD (ChlR)

This study

For purification of CpdR D9G D51A DD (ChlR)

This study

E. coli plasmid for expressing T25- CpdR D9G D11E
K97R using Plac (KanR)
E. coli plasmid for expressing T25- CpdR D9G S100F
H104A using Plac (KanR)
E. coli plasmid for expressing T25- CpdR D9N S100F
H104A using Plac (KanR)
E. coli plasmid for expressing T25- CpdR D9N V103M
H104A using Plac (KanR)
E. coli plasmid for expressing T25- CpdR D9G using Plac
(KanR)
E. coli plasmid for expressing T25- CpdR D9G R106A
using Plac (KanR)
E. coli plasmid for expressing T25- CpdR D9G H104A
using Plac (KanR)
E. coli plasmid for expressing T25- CpdR D51A using
Plac (KanR)

This study
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This study
This study
This study
This study
This study
This study
This study

APPENDIX 2
PROTEIN PROPERTIES OF CPDR WILDTYPE COMPARED TO ITS R106A
AND H104A VARIANTS
(A) There is no noticeable difference between the patterns of unfolding for
CpdR wildtype and variants R106A and H104A. (i) The intrinsic fluorescence
of CpdR is measured when natively folded and when unfolded using 7M
guanidium HCl as a denaturant. Center of mass (COM) is measured for the
fluorescence plots. CpdR red-shifts from 354.14 nm to 367.5 nm when unfolded.
(ii) The intrinsic fluorescence (based on COM measurements) of CpdR variants
is compared to CpdR wildtype.

(B) CpdR wildtype and variants, R106A and H104A, are phosphorylatable. In
vitro phosphorelay profiling of CpdR wildtype (WT), and variants R106A and
H104A using radiolabeled ATP (32P). A split version of CckA in which the
histidine kinase (CckA-HK) and receiver domains (CckA-RD) are separate
polypeptides were used to minimize dephosphorylation (Chen et al., 2009). ChpT
is a phosphotransferase that mediates phosphotransfer from CckA to CpdR
(Biondi et al., 2006b).
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APPENDIX 1
FULL-SIZE GELS OF SEC PROFILES OF CPDR, PDEA, AND CLPX SEC
profiles of CpdR (±PdeA/ClpX/ATPγS), as shown in Figure 2-8A,B, are shown in
full size. 36 fractions from the SEC were analyzed across two separate twentywell SDS-PAGE gels. Gels were stained with Coomassie stain prior to silver
stain. Molecular weight ladder was loaded in equivalent amounts in two lanes per
gel (Thermo Scientific unstained protein molecular weight marker 1/10 dilution in
one well, and 1/50 dilution in the well after). In these SEC experiments, 20µM
CpdR/5µM PdeA/5µM ClpX6/5mM(sample mixture) or 1mM (in running buffer)
ATPγS were used, with 1mM GTP throughout.
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APPENDIX 2
DATA RELATED TO THE NATIVE AND NON-DEGRADABLE VARIANTS OF
THE ADAPTORS SSPB AND CPDR
(A) In vitro degradation of SspB* (residues 11-162) versus wildtype SspB
(1-162) by ClpXP. C. crescentus SspB (1-162) is degradable unless its Nterminus ten amino acid is removed to reveal an alternative methionine start site
which produces a stable, but completely active form of SspB (Chien et al.,
2007b).

Degradation of full length SspB (residues 1-162) and stable SspB*

(residues 11-162) (4µM) by ClpXP (0.2µM ClpX6, 0.4µM ClpP14) are shown for
comparison.

(B) In vitro degradation of CpdR wildtype (WT) and its non-degradable
variant CpdRDD (C-terminal Ala-Ala mutated to Asp-Asp) by ClpXP. CpdR
WT and CpdRDD (10µM) degradation by ClpXP (0.2µM ClpX6, 0.4µM ClpP14)
are shown for comparison.

(C) The non-degradable variant CpdRDD mediates ClpXP degradation of
PdeA in vitro. The adaptor function of CpdR WT and CpdRDD (2µM) evaluated
by comparing their activity in mediating degradation of PdeA (1µM, in the
presence of 1mM GTP) by ClpXP (0.4µM ClpX6, 0.8µM ClpP14).
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(D) The non-degradable variant CpdRDD interacts with ClpX. Size exclusion
chromatography profiles of 20µM CpdR WT/DD in the presence of 5µM ClpX6.
Protein profiles were determined by silver staining.

(E) Wildtype SspB and non-degradable variant SspB* show similar
concentration-dependent adaptor activity. In vitro degradation of GFP-ssrASS (1µM) by ClpXP (0.2µM ClpX6, 0.4µM ClpP14) in the presence of increasing
concentrations of SspB or the non-degradable SspB*.

(F) Non-degradable CpdRDD does not suppress substrate delivery,
however

CpdR

wildtype

can

suppress

substrate

delivery

due

to

competition for degradation with its own substrate. In vitro degradation of
substrate GFP-PdeA (1µM) by ClpXP (0.2µM ClpX6, 0.4µM ClpP14) in the
presence of increasing concentrations of CpdR WT/DD. (i and ii) show the
activity from two independent purification of CpdRWT/DD proteins.

(G) Effect of SspB(SBD) on levels of GFP-ssrA-SS in vivo (related to Figure
3-8). As described in Figure 3-8, Flag-tagged GFP-ssrA-SS reporter (detected by
Western α-GFP) was integrated in C. crescentus at the chromosomal vanA locus
and expressed by addition of 1mM vanillate. SspB(substrate binding domain,
SBD, residue 1-125) is expressed from a high-copy plasmid JS14 (repressible by
0.2% glucose and inducible by 0.2% xylose, detected by Western blotting
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with α-FLAG). Impact of FLAG-SspB(SBD) expression on FLAG-GFP-ssrA-SS
levels is compared to a strain harboring JS14 (empty plasmid) and a ∆sspB
strain harboring JS14 (empty plasmid).

(H) In vitro degradation profile of the non-degradable variant of
CpdRH104A,

CpdRH104ADD.

(i)

CpdR

WT/H104A/H104ADD

(10µM)

degradation by ClpXP (0.4µM ClpX6, 0.8µM ClpP14) was evaluated. (ii) Adaptor
activity of CpdRH104ADD was compared to CpdRH104A and CpdRDD. In vitro
degradation performed using 1µM GFP-PdeA reporter substrate, 1mM GTP,
0.4µM ClpX6, 0.8µM ClpP14. CpdRH104ADD is more active than CpdRH104A,
perhaps because CpdRH104A is also a degradation substrate for ClpXP.

(I) Effect of CpdRH104ADD on PdeA levels in vivo (related to Figure 3-8).
As described in Figure 3-8, FLAG-tagged PdeA reporter is chromosomally
integrated in C. crescentus for vanillate-induced expression, and FLAG-tagged
CpdRH104ADD is expressed from the plasmid JS14 (both detected by Western
blotting with α-FLAG). Impact of FLAG-CpdRH104ADD expression on FLAGPdeA levels is compared to a strain harboring JS14 (empty plasmid) and a
∆cpdR::tet strain harboring JS14 (empty plasmid).
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APPENDIX 3
IN VIVO EXPRESSION LEVELS OF FLAG M2-TAGGED CPDR VARIANTS IN
C. CRESCENTUS STRAINS
C. crescentus strains expressing CpdR variants were grown at 30°C in a shaking
incubator in PYE containing the relevant antibiotics overnight before dilution into
fresh antibiotic-containing media supplemented with 0.2% xylose for 6 hours
induction. Cells were harvested at exponential phase (OD600<1). Cell density
(OD600) measurements were used to normalize the amounts of cells harvested
for each sample. Flag-M2-tagged CpdR were detected by Western using -Flag
(filled triangles). ClpX or ClpP detected by Western using

-ClpX or

-ClpP

respectively (unfilled triangles) were used as loading control.

(A) CpdR expression levels using pRX2-M2 in C. crescentus ∆cpdR strain
(B) CpdR expression levels using pHX-M2 in C. crescentus wildtype strain
(C) CpdR expression levels using pHX-M2 in C. crescentus ∆pdeA strain
(D) CpdR expression levels using pHX-M2 in C. crescentus ∆cpdR ∆cpdR PxylclpX-gfp strain.
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